CA2482202C - Systems and methods for magnetic-resonance-guided interventional procedures - Google Patents
Systems and methods for magnetic-resonance-guided interventional procedures Download PDFInfo
- Publication number
- CA2482202C CA2482202C CA2482202A CA2482202A CA2482202C CA 2482202 C CA2482202 C CA 2482202C CA 2482202 A CA2482202 A CA 2482202A CA 2482202 A CA2482202 A CA 2482202A CA 2482202 C CA2482202 C CA 2482202C
- Authority
- CA
- Canada
- Prior art keywords
- conductor
- probe
- electrode
- electrically coupled
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/08—Arrangements or circuits for monitoring, protecting, controlling or indicating
- A61N1/086—Magnetic resonance imaging [MRI] compatible leads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/285—Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR
- G01R33/287—Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR involving active visualization of interventional instruments, e.g. using active tracking RF coils or coils for intentionally creating magnetic field inhomogeneities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/374—NMR or MRI
Abstract
Herein is disclosed a probe, including a first electrode disposed at least partially on the probe surface, a second electrode disposed at least partially on the probe surface, a first conductor electrically coupled to the first electrode, a second conductor electrically coupled to the second electrode, and a reactive element electrically coupling the first conductor and the second conductor.
Description
SYSTEMS AND METHODS FOR MAGNETIC-RESONANCE-GUIDED
INTERVENTIONAL PROCEDURES
BACKGROUND
INTERVENTIONAL PROCEDURES
BACKGROUND
[02] The disclosed systems and methods relate in general to ablation and electrophysiologic diagnostic and therapeutic procedures, and in particular to systems and methods for performing, guiding, and providing visualization of such procedures.
[03] Atrial fibrillation and ventricular tachyarrhythmias occurring in patients with structurally abnormal hearts are of great concern in contemporary cardiology.
They represent the most frequently encountered tachycardias, account for the most morbidity and mortality, and, despite much progress, remain therapeutic challenges.
They represent the most frequently encountered tachycardias, account for the most morbidity and mortality, and, despite much progress, remain therapeutic challenges.
[04] Atrial fibrillation affects a larger population than ventricular tachyarrhythmias, with a prevalence of approximately 0.5% in patients 50-59 years old, increasing to 8.8% in patients in their 80's. Framingham data indicate that the age-adjusted prevalence has increased substantially over the last 30 years, with over 2 million people in the United States affected. Atrial fibrillation usually accompanies disorders such as coronary heart disease, cardiomyopathies, and the postoperative state, but occurs in the absence of any recognized abnormality in 10%
of cases. Although it may not carry the inherent lethality of a ventricular tachyarrhythmia, it does have a mortality twice that of control subjects.
Symptoms which occur during atrial fibrillation result from the often rapid irregular heart rate and the loss of atrio-ventricular (AV) synchrony. These symptoms, side effects of drugs, and most importantly, thrombo-embolic complications in the brain (leading to approximately 75,000 strokes per year), make atrial fibrillation a formidable challenge.
of cases. Although it may not carry the inherent lethality of a ventricular tachyarrhythmia, it does have a mortality twice that of control subjects.
Symptoms which occur during atrial fibrillation result from the often rapid irregular heart rate and the loss of atrio-ventricular (AV) synchrony. These symptoms, side effects of drugs, and most importantly, thrombo-embolic complications in the brain (leading to approximately 75,000 strokes per year), make atrial fibrillation a formidable challenge.
[05] Two strategies have been used for medically managing patients with atrial fibrillations. The first involves rate control and anticoagulation, and the second involves attempts to restore and maintain sinus rhythm. The optimal approach is uncertain. In the majority of patients, attempts are made to restore sinus rhythm with electrical or pharmacologic cardioversion. Current data suggest anticoagulation is needed for 3 to 4 weeks prior to and 2 to 4 weeks following cardioversion to prevent embolization associated with the cardioversion. Chronic antiarrhythmic therapy may be indicated once sinus rhythm is restored. Overall, pharmacologic, therapy is successful in maintaining sinus rhythm in 30 to 50% of patients over one to two years of follow-up. A major disadvantage of antiarrhythmic therapy is the induction of sustained, and sometimes lethal, arrhythmias (proarrhythmia) in up to 10% of patients.
[06] If sinus rhythm cannot be maintained, several approaches are used to control the ventricular response to atrial fibrillation. Pharmacologic agents which slow conduction through the AV node are first tried. When pharmacologic approaches to rate control fail, or result in significant side effects, ablation of the AV
node, and placement of a permanent pacemaker may be considered. The substantial incidence of thromboembolic strokes makes chronic anticoagulation important, but bleeding complications are not unusual, and anticoagulation cannot be used in all patients.
node, and placement of a permanent pacemaker may be considered. The substantial incidence of thromboembolic strokes makes chronic anticoagulation important, but bleeding complications are not unusual, and anticoagulation cannot be used in all patients.
[07] In addition to medical management approaches, surgical therapy of atrial fibrillation has also been performed. The surgical-maze procedure, developed by Cox, is an approach for suppressing atrial fibrillation while maintaining atrial functions.
This procedure involves creating multiple linear incisions in the left and night atria.
These surgical incisions create lines that block conduction and compartmentalize the atrium into distinct segments that remain in communication with the sinus node. By reducing the mass of atrial tissue in each segment, the mass of atrial tissue is insufficient to sustain the multiple reentrant rotors, which are the basis for atrial fibrillation. Surgical approaches to the treatment of atrial fibrillation result in an efficacy of > 95% and a low incidence of complications. However, despite these encouraging results, this procedure has not gained widespread acceptance because of the long duration of recovery and risks associated with cardiac surgery.
This procedure involves creating multiple linear incisions in the left and night atria.
These surgical incisions create lines that block conduction and compartmentalize the atrium into distinct segments that remain in communication with the sinus node. By reducing the mass of atrial tissue in each segment, the mass of atrial tissue is insufficient to sustain the multiple reentrant rotors, which are the basis for atrial fibrillation. Surgical approaches to the treatment of atrial fibrillation result in an efficacy of > 95% and a low incidence of complications. However, despite these encouraging results, this procedure has not gained widespread acceptance because of the long duration of recovery and risks associated with cardiac surgery.
[08] Invasive studies of the electrical activities of the heart (electrophysiologic studies) have also been used in the diagnosis and therapy of arrhythmias.
Focal atrial tachycardias, AV-nodal reentrant tachycardias, accessory pathways, atrial flutter, and idiopathic ventricular tachycardia can be cured by selective destruction of critical electrical pathways with radiofrequency (RF) catheter ablation.
Electrophysiologists have attempted to replicate the maze procedure using RF catheter ablation. The procedure is arduous, requiring general anesthesia and procedure durations often greater than 12 hours, with exposure to ionizing x-ray irradiation for over 2 hours.
Some patients have sustained cerebrovascular accidents. One of the main limitations of the procedure is the difficulty associated with creating and confirming the presence of continuous linear lesions in the atrium. If the linear lesions have gaps, then activation can pass through the gap and complete a reentrant circuit, thereby sustaining atrial fibrillation or flutter. This difficulty contributes significantly to the long procedure durations discussed above.
Focal atrial tachycardias, AV-nodal reentrant tachycardias, accessory pathways, atrial flutter, and idiopathic ventricular tachycardia can be cured by selective destruction of critical electrical pathways with radiofrequency (RF) catheter ablation.
Electrophysiologists have attempted to replicate the maze procedure using RF catheter ablation. The procedure is arduous, requiring general anesthesia and procedure durations often greater than 12 hours, with exposure to ionizing x-ray irradiation for over 2 hours.
Some patients have sustained cerebrovascular accidents. One of the main limitations of the procedure is the difficulty associated with creating and confirming the presence of continuous linear lesions in the atrium. If the linear lesions have gaps, then activation can pass through the gap and complete a reentrant circuit, thereby sustaining atrial fibrillation or flutter. This difficulty contributes significantly to the long procedure durations discussed above.
[09] Creating and confirming continuous linear lesions and morbidity could be facilitated by improved minimally-invasive techniques for imaging lesions created in the atria. Such an imaging technique may allow the procedure to be based purely on anatomic findings.
[10] The major technology for guiding placement of a catheter is x-ray fluoroscopy. For electrophsiologic studies and ablation, frame rates of 7-15 per second are generally used which allows an operator to see x-ray-derived shadows of the catheters inside the body. Since x-rays traverse the body from one side to the other, all of the structures that are traversed by the x-ray beam contribute to the image. The image, therefore is a superposition of shadows from the entire thickness of the body. Using one projection, therefore, it is only possible to know the position of the catheter perpendicular to the direction of the beam. In order to gain information about the position of the catheter parallel to the beam, it is necessary to use a second beam that is offset at some angle from the original beam, or to move the original beam to another angular position. Since x-ray shadows are the superposition of contributions from many structures, and since the discrimination of different soft tissues is not great, it is often very difficult to determine exactly where the catheter is within the heart. In addition, the borders of the heart are generally not accurately defined, so it is generally not possible to know if the catheter has penetrated the wall of the heart, and lesions are invisible under x-ray fluoroscopy. Thus, it is very difficult to discern whether tissue has been adequately ablated. The intracardiac electrogram may be used to guide the catheters to the proper cardiac tissue.
[11] Intracardiac ultrasound has been used to overcome deficiencies in identifying soft tissue structures. With ultrasound it is possible to determine exactly where the walls of the heart are with respect to a catheter and the ultrasound probe, but the ultrasound probe is mobile, so there can be doubt where the absolute position of the probe is with respect to the heart.
[12] Neither x-ray fluoroscopy nor intracardiac ultrasound have the ability to accurately and reproducibly identify areas of the heart that have been ablated.
[13] A system known as "non-fluoroscopic electro-anatomic mapping" (U.S.
Patent No. 5,391,199 to Ben-Haim), was developed to allow more accurate positioning of catheters within the heart. That system uses weak magnetic fields and a calibrated magnetic field detector to track the location of a catheter in 3-space. The system can mark the position of a catheter, but the system relies on having the heart not moving with respect to a marker on the body. The system does not obviate the need for initial placement using x-ray fluoroscopy, and cannot directly image ablated tissue.
Patent No. 5,391,199 to Ben-Haim), was developed to allow more accurate positioning of catheters within the heart. That system uses weak magnetic fields and a calibrated magnetic field detector to track the location of a catheter in 3-space. The system can mark the position of a catheter, but the system relies on having the heart not moving with respect to a marker on the body. The system does not obviate the need for initial placement using x-ray fluoroscopy, and cannot directly image ablated tissue.
[14] Magnetic resonance imaging (MRI) is a known imaging technique which uses high-strength magnetic and electric fields to image the body. A strong static magnetic field orients the magnetic moments of the hydrogen nuclei creating a bulk nuclear magnetization. RF magnetic field pulses with frequency tuned to the resonant or "Larmor" frequency in the presence of the static field, change the spatial orientation of the bulk magnetization of the nuclei, as known to those skilled in the art.
In addition, time-varying gradient magnetic fields applied in the three Cartesian directions (X, Y, Z) are used for spatial encoding of the signals from the tissue. The magnitude of a gradient magnetic field is such as to cause the main static magnetic field to vary linearly as a function of the respective spatial coordinate in the magnet.
As a result of the addition of the static and gradient magnetic fields, the local Larmor resonance frequency, is spatially encoded. The information corresponding to the strength of the magnetization at each point in space can then be decoded by means of reconstruction techniques known to those skilled in the art, permitting the imaging of tissues in three-dimensional space.
In addition, time-varying gradient magnetic fields applied in the three Cartesian directions (X, Y, Z) are used for spatial encoding of the signals from the tissue. The magnitude of a gradient magnetic field is such as to cause the main static magnetic field to vary linearly as a function of the respective spatial coordinate in the magnet.
As a result of the addition of the static and gradient magnetic fields, the local Larmor resonance frequency, is spatially encoded. The information corresponding to the strength of the magnetization at each point in space can then be decoded by means of reconstruction techniques known to those skilled in the art, permitting the imaging of tissues in three-dimensional space.
[15] MRI has been used to guide procedures in which RF energy is applied to non-contractile organs such as the brain, liver and kidneys to ablate tumors.
However, these systems are not suitable for use in the heart. U.S. Patent No. 5,323,778 to Kandarpa et al. discloses a method and apparatus for MRI and tissue heating.
There is no provision in the disclosed probe for measuring electrical signals, and it is unclear how much resolution is provided by the probe.
SUMMARY
However, these systems are not suitable for use in the heart. U.S. Patent No. 5,323,778 to Kandarpa et al. discloses a method and apparatus for MRI and tissue heating.
There is no provision in the disclosed probe for measuring electrical signals, and it is unclear how much resolution is provided by the probe.
SUMMARY
[16] The systems and methods disclosed herein enhance the art by, among other things, facilitating the performance of multiple functions during electrophysiological interventions with MRI. An embodiment provides an instrument that can be easily visualized and/or tracked in an MR or other image. An embodiment provides an instrument that can be easy to maneuver. An embodiment provides an instrument that can facilitate high resolution imaging of a target area. An embodiment provides an instrument that can record an intracardiac electrogram. An embodiment provides an instrument that can deliver RF energy for ablation of the desired tissue near the instrument tip.
[17] An embodiment provides an improved multi-functional systems and methods for guiding and/or providing visualization during electrophysiologic procedures.
[18] In an embodiment, the disclosed systems and methods facilitate guiding or visualizing ablation procedures suitable for use in, e.g., the heart and other structures.
[19] In an embodiment, the disclosed systems and methods include catheters that are easy to maneuver and/or track.
[20] In an embodiment, the disclosed systems and methods facilitate imaging ablation lesions with increased resolution of the target area and reliability.
[21] In an embodiment, the disclosed systems and methods facilitate delivering RF
energy for ablation of tissue, including but not limited to pathologic tissue.
energy for ablation of tissue, including but not limited to pathologic tissue.
[22] In an embodiment, the disclosed systems and methods facilitate recording and monitoring electrical potentials, including but not limited to physiologic bio-potentials.
[23] In an embodiment, the disclosed systems and methods facilitate determining the position of, e.g., target tissue or an ablation instrument.
[24] In an embodiment, the disclosed systems and methods facilitate guiding the delivery of RF ablation energy.
[25] In an embodiment, the disclosed systems and methods facilitate the integration of imaging and ablation in a single instrument.
[26] In an embodiment, the disclosed systems and methods facilitate using magnetic resonance imaging to increase the safety and accuracy of electrophysiologic procedures.
[27] In an embodiment, the disclosed systems and methods provide an invasive multi-functional electrophysiology and imaging antenna catheter which includes an RF antenna for receiving magnetic resonance signals, a loop antenna for device tracking, an ablation tip for delivering RF energy for ablation procedures, and diagnostic electrodes for receiving physiological electrical potentials. The combined electrophysiology and imaging antenna catheter can be used in combination with a MRI scanner to, for example, guide, perform, and/or provide visualization during electrophysiologic diagnostic or therapeutic procedures.
[28] In an embodiment, the disclosed systems and methods can be particularly applicable to ablation of atrial and ventricular arrhythmias, and in such embodiments may be used as an intracardiac device to both deliver energy to selected areas of tissue and visualize the resulting ablation lesions, thereby greatly simplifying production of continuous linear lesions. Additionally, the disclosed systems and methods can be used as active tracking devices by means of a "loop antenna" that receives MRI
signals excited by the scanner. Gradient echoes are then generated along three orthogonal axes to frequency encode the location of the coil and thus provide the three-dimensional (3D) space coordinates of the electrode tip. These numeric coordinates can then be used to control the imaging plane of the scanner, thereby allowing accurate imaging slices to be prescribed to target anatomy for RF
therapy.
Low resolution images can be obtained indicating catheter location relative to the body by combining the MRI signals from the loop with those of the conventional external MRI detector coil. In addition, high resolution images can be obtained using the signals from the loop antenna. In another embodiment, the loop antenna utilized in the combined electrophysiology and imaging catheter for receiving MRI signals is connected to form a "loopless" type antenna. High-resolution images from the antenna may be combined with low-resolution images from surface coils of the MR
scanner to produce a composite image. The disclosed systems and methods further include embodiments useful for guiding electrophysiologic diagnostic and therapeutic procedures other than ablation. An RF filtering system is provided for suppressing the MRI signal while not attenuating the RF ablative current. Steering means may be provided for steering the invasive catheter under MR guidance. Steering could be facilitated by proving a probe with a pull wire. In addition, the disclosed systems and methods include acquisition of local physiological bio-potential measurements using a multi-electrode catheter, which permits, via MRI guidance, active tracking of the location of each electrode. A central novel feature of the disclosed systems and methods is that because bio-potentials, RF ablation, and MRI are each performed over different frequency ranges, frequency-dependent circuit elements can be used to change the catheter's electrical structure enabling it to provide multiple electrical structures within a single physical structure.
signals excited by the scanner. Gradient echoes are then generated along three orthogonal axes to frequency encode the location of the coil and thus provide the three-dimensional (3D) space coordinates of the electrode tip. These numeric coordinates can then be used to control the imaging plane of the scanner, thereby allowing accurate imaging slices to be prescribed to target anatomy for RF
therapy.
Low resolution images can be obtained indicating catheter location relative to the body by combining the MRI signals from the loop with those of the conventional external MRI detector coil. In addition, high resolution images can be obtained using the signals from the loop antenna. In another embodiment, the loop antenna utilized in the combined electrophysiology and imaging catheter for receiving MRI signals is connected to form a "loopless" type antenna. High-resolution images from the antenna may be combined with low-resolution images from surface coils of the MR
scanner to produce a composite image. The disclosed systems and methods further include embodiments useful for guiding electrophysiologic diagnostic and therapeutic procedures other than ablation. An RF filtering system is provided for suppressing the MRI signal while not attenuating the RF ablative current. Steering means may be provided for steering the invasive catheter under MR guidance. Steering could be facilitated by proving a probe with a pull wire. In addition, the disclosed systems and methods include acquisition of local physiological bio-potential measurements using a multi-electrode catheter, which permits, via MRI guidance, active tracking of the location of each electrode. A central novel feature of the disclosed systems and methods is that because bio-potentials, RF ablation, and MRI are each performed over different frequency ranges, frequency-dependent circuit elements can be used to change the catheter's electrical structure enabling it to provide multiple electrical structures within a single physical structure.
[29] In an embodiment, a probe or catheter includes a first electrode disposed at least partially on the probe surface, a second electrode disposed at least partially on the probe surface, a first conductor electrically coupled to the first electrode, a second conductor electrically coupled to the second electrode, and a reactive element electrically coupling the first conductor and the second conductor.
[30] In an embodiment, a magnetic resonance imaging probe includes a coaxial cable having an inner conductor and an outer shield, a first split ring electrode electrically coupled to the inner conductor, and a second split ring electrode electrically coupled to the outer conductor, a first center split ring electrode electrically coupled to the first split ring electrode and to a first conductor, a second center split ring electrode electrically coupled to the first center split ring electrode and to the second split ring electrode, and also coupled to a second conductor.
[31] In an embodiment, a magnetic resonance imaging probe includes a first electrode disposed on the probe surface, a second electrode disposed on the probe surface, a first conductor electrically coupled to the first electrode through a reactance, a second conductor electrically coupled to the second electrode through a reactance, and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor.
[32] In an embodiment, a system for magnetic resonance imaging includes a magnetic resonance imaging probe, having a first electrode disposed on the probe surface, a second electrode disposed on the probe surface, a first conductor electrically coupled to the first electrode through a reactance, a second conductor electrically coupled to the second electrode through a reactance, and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor; and an interface electrically coupled to the probe, the interface having a tuning/matching/decoupling circuit and a signal splitting circuit;
and an MRI scanner electrically coupled to the interface.
and an MRI scanner electrically coupled to the interface.
[33] In an embodiment, a magnetic resonance imaging probe includes a coaxial cable having an inner conductor and an outer shield, and a split ring electrode having a first portion and a second portion, the first portion being electrically coupled to the inner conductor, and the second portion being electrically coupled to the outer shield.
[34] In an embodiment, a magnetic resonance imaging probe may include a coaxial cable having an inner conductor and an outer shield, a first split ring electrode electrically coupled to the inner conductor, and a second split ring electrode electrically coupled to the outer conductor; wherein the first split ring and the second split ring are electrically coupled by a first reactive element.
[35] In an embodiment, the reactive element can conduct a high frequency signal between the first conductor and the second conductor. In an embodiment, the high frequency signal has a frequency higher than about 10 MegaHertz (MHz). In an embodiment, the reactive element can conduct a signal having magnetic resonance imaging frequency energy between the first conductor and the second conductor.
[36] In an embodiment, at least one of the first conductor and the second conductor can conduct a low frequency signal to at least one of the first electrode and the second electrode. In an embodiment, the low frequency signal has a frequency of up to about 500 kiloHertz (kHz). In an embodiment, the low frequency is in the range from about 100 Hertz (Hz) to about 1 kHz. In an embodiment, the frequency is about 100 kHz.
[37] In an embodiment, the reactive element conducts a signal having ablation frequency energy to at least one of the first electrode and the second electrode. In an embodiment, the reactive element conducts a signal having biopotential recording frequency energy to at least one of the first electrode and the second electrode.
[38] In an embodiment, the probe further comprises a lumen.
[39] In an embodiment, the reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, and a capacitor. In an embodiment, the reactance comprises at least one of an inductor and an LC circuit.
[40] In an embodiment, the first conductor couples to the first electrode through a reactance. In an embodiment, at least one of the first conductor, the second conductor, the first electrode, and the second electrode comprises at least one of a magnetic resonance compatible material, a superelastic material, copper, gold, silver, platinum, iridium, MP35N, tantalum, titanium, Nitinol, L605, gold-platinum-iridium, gold-copper-iridium, and gold-platinum.
[41] In an embodiment, the first conductor and the second conductor are electrically coupled to a tuning/matching/decoupling circuit. In an embodiment, the first conductor and the second conductor are electrically coupled to a signal splitting circuit. In an embodiment, the first conductor and the second conductor are electrically coupled by at least one capacitor.
[42] An embodiment may further include a third conductor electrically coupled to a third electrode, and a fourth conductor electrically coupled to a fourth electrode, wherein a first signal having high frequency energy is conducted between the first conductor and the second conductor through the reactive element, and a second signal having low frequency energy is conducted to at least one of the third electrode and the fourth electrode.
[43] An embodiment may further include a shaft, the shaft including at least one of Kevlar, nylon, Teflon, polyethylene, polyolefin, PTFE, polyurethane, PEBAX, braided Kevlar, and braided nylon. In an embodiment, the probe surface is covered by a lubricious coating.
[44] In an embodiment, the probe has an outer diameter in the range of about 1 French to about 15 French. In an embodiment, the probe has a length in the range of about 50 cm to about 200 cm. In an embodiment, the probe further comprises a pull wire.
[45] In an embodiment, the first conductor, the reactive element, and the second conductor form a loop antenna. In an embodiment, the first conductor, the reactive element, and the second conductor form a loopless antenna.
[46] In an embodiment, the inner conductor and the outer shield are electrically coupled by a reactive element. In an embodiment, the reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, and a capacitor. In an embodiment, the inner conductor and the outer shield are electrically coupled by a second reactive element. In an embodiment, the second reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, and a capacitor. In an embodiment, the first reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, and a capacitor.
[47] In an embodiment, a method for simultaneously imaging and ablating a tissue can include exposing the tissue to a magnetic field, the field having a static component and a gradient component, placing a probe adjacent to the tissue, the probe including a first electrode disposed at least partially on the probe surface, a second electrode disposed at least partially on the probe surface, a first conductor electrically coupled to the first electrode, a second conductor electrically coupled to the second electrode, and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency energy is conducted to at least one of the first electrode and the second electrode;
directing low-frequency energy to the probe, the low frequency energy being conducted to the tissue by at least one of the first electrode and the second electrode; and receiving high-frequency energy from at least one of the first conductor and the second conductor for imaging at least one of the probe and the tissue.
directing low-frequency energy to the probe, the low frequency energy being conducted to the tissue by at least one of the first electrode and the second electrode; and receiving high-frequency energy from at least one of the first conductor and the second conductor for imaging at least one of the probe and the tissue.
[48] In an embodiment, a method for simultaneously imaging a tissue and measuring a bioelectric potential in the tissue may include exposing the tissue to a magnetic field, the field having a static component and a gradient component, placing a probe adjacent to the tissue, the probe including a first electrode disposed at least partially on the probe surface, a second electrode disposed at least partially on the probe surface, a first conductor electrically coupled to the first electrode, a second conductor electrically coupled to the second electrode, and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency energy is conducted to at least one of the first electrode and the second electrode; receiving low-frequency energy from the probe, the low frequency energy being conducted from at least one of the first electrode and the second electrode; and receiving high-frequency energy from at least one of the first conductor and the second conductor for imaging at least one of the probe and the tissue.
[49] In an embodiment, a method for simultaneously imaging a tissue, ablating the tissue, and measuring a bioelectric potential in the tissue may include exposing the tissue to a magnetic field, the field having a static component and a gradient component, placing a probe adjacent to the tissue, the probe including a first electrode disposed at least partially on the probe surface, a second electrode disposed at least partially on the probe surface, a first conductor electrically coupled to the first electrode, a second conductor electrically coupled to the second electrode, and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low-frequency and medium-frequency energy is conducted to at least one of the first electrode and the second electrode;
receiving low-frequency energy from the probe, the low frequency energy being conducted from at least one of the first electrode and the second electrode, directing medium-frequency energy to the probe, the medium-frequency energy being conducted to the tissue by at least one of the first electrode and the second electrode, and receiving high-frequency energy from the probe, the high-frequency energy having magnetic resonance imaging data.
receiving low-frequency energy from the probe, the low frequency energy being conducted from at least one of the first electrode and the second electrode, directing medium-frequency energy to the probe, the medium-frequency energy being conducted to the tissue by at least one of the first electrode and the second electrode, and receiving high-frequency energy from the probe, the high-frequency energy having magnetic resonance imaging data.
[50] In an embodiment, a method for simultaneously imaging and treating a tissue may include exposing the tissue to a magnetic field, the field having a static component and a gradient component, placing a probe adjacent to the tissue, the probe including a first electrode disposed at least partially on the probe surface, a second electrode disposed at least partially on the probe surface, a first conductor electrically coupled to the first electrode, a second conductor electrically coupled to the second electrode, and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor;
delivering a therapy to the tissue, and receiving high-frequency energy from the probe, the high-frequency energy having magnetic resonance imaging data.
[50a] According to another aspect, there is provided a probe, comprising:
a matching circuit;
a first electrode residing on a distal end portion of the probe;
a second electrode residing spaced apart from the first electrode on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode and extending from the matching circuit;
a second conductor electrically coupled to the second electrode and extending from the matching circuit; and a reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor, wherein the first and second conductors and the reactive element form a loop antenna for a high frequency signal received by the probe.
[50b] According to another aspect, there is provided a magnetic resonance imaging probe, comprising:
a coaxial cable including an inner conductor and an outer shield; and - 12a -a split ring electrode including a first portion and a second portion, the first portion being electrically coupled to the inner conductor, and the second portion being electrically coupled to the outer shield.
[50c] According to a further aspect, there is provided a magnetic resonance imaging probe, comprising:
a cable including an inner conductor and an outer shield;
at least one electrode electrically coupled to the inner conductor; and at least one electrode electrically coupled to the outer conductor;
wherein the at least one electrode coupled to the inner conductor and the at least one electrode coupled to the outer shield are electrically coupled by at least one reactive element.
[50d] According to another aspect, there is provided a magnetic resonance imaging probe, comprising:
a coaxial cable including an inner conductor and an outer shield;
a first split ring electrode electrically coupled to the inner conductor; and a second split ring electrode electrically coupled to the outer shield;
a first center split ring electrode electrically coupled to the first split ring electrode and to a first conductor;
a second center split ring electrode electrically coupled to the first center split ring electrode and to the second split ring electrode, and also coupled to a second conductor.
[50e] According to a further aspect, there is provided a magnetic resonance imaging probe, comprising:
a matching circuit;
a first electrode disposed on a probe surface;
a second electrode disposed on the probe surface;
a first conductor extending from the matching circuit and electrically coupled to the first electrode through a reactance;
a second conductor extending from the matching circuit and electrically coupled to the second electrode through a reactance; and - 12b-a frequency-dependent reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor to form a loop antenna.
[50f] According to another aspect, there is provided a system for magnetic resonance imaging, comprising:
a magnetic resonance imaging probe, including:
a first electrode disposed on a distal end portion of the probe;
a second electrode disposed on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode through a reactance;
a second conductor electrically coupled to the second electrode through a reactance; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor;
an interface electrically coupled to the probe, the interface including a tuning/matching/decoupling circuit and a signal splitting circuit; and an MRI scanner electrically coupled to the interface.
[50g] According to a further aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging and ablating the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe comprises:
a first electrode disposed at least partially on a probe surface;
a second electrode disposed at least partially on the probe surface;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is - 12c-conducted between the first conductor and the second conductor, and low frequency ablating energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency ablating energy of at least one of the first electrode or the second electrode is capable of ablating the tissue;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy received at the probe.
[50h] According to another aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging the tissue and measuring a bioelectric potential in the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe has a probe surface and the probe further comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy.
150i] According to a further aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging a tissue, ablating the tissue, and measuring a bioelectric potential in the tissue, wherein the magnetic field - 12d -comprises a static component and a gradient component and wherein the probe has a probe surface and the probe further comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low-frequency and medium-frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
ablating energy is directable to the probe, the ablating energy is conductible to the tissue by at least one of the first electrode or the second electrode;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
150j) According to another aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging and treating a tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor;
wherein a therapy is deliverable to the tissue using the probe;
- 12e-the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
delivering a therapy to the tissue, and receiving high-frequency energy from the probe, the high-frequency energy having magnetic resonance imaging data.
[50a] According to another aspect, there is provided a probe, comprising:
a matching circuit;
a first electrode residing on a distal end portion of the probe;
a second electrode residing spaced apart from the first electrode on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode and extending from the matching circuit;
a second conductor electrically coupled to the second electrode and extending from the matching circuit; and a reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor, wherein the first and second conductors and the reactive element form a loop antenna for a high frequency signal received by the probe.
[50b] According to another aspect, there is provided a magnetic resonance imaging probe, comprising:
a coaxial cable including an inner conductor and an outer shield; and - 12a -a split ring electrode including a first portion and a second portion, the first portion being electrically coupled to the inner conductor, and the second portion being electrically coupled to the outer shield.
[50c] According to a further aspect, there is provided a magnetic resonance imaging probe, comprising:
a cable including an inner conductor and an outer shield;
at least one electrode electrically coupled to the inner conductor; and at least one electrode electrically coupled to the outer conductor;
wherein the at least one electrode coupled to the inner conductor and the at least one electrode coupled to the outer shield are electrically coupled by at least one reactive element.
[50d] According to another aspect, there is provided a magnetic resonance imaging probe, comprising:
a coaxial cable including an inner conductor and an outer shield;
a first split ring electrode electrically coupled to the inner conductor; and a second split ring electrode electrically coupled to the outer shield;
a first center split ring electrode electrically coupled to the first split ring electrode and to a first conductor;
a second center split ring electrode electrically coupled to the first center split ring electrode and to the second split ring electrode, and also coupled to a second conductor.
[50e] According to a further aspect, there is provided a magnetic resonance imaging probe, comprising:
a matching circuit;
a first electrode disposed on a probe surface;
a second electrode disposed on the probe surface;
a first conductor extending from the matching circuit and electrically coupled to the first electrode through a reactance;
a second conductor extending from the matching circuit and electrically coupled to the second electrode through a reactance; and - 12b-a frequency-dependent reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor to form a loop antenna.
[50f] According to another aspect, there is provided a system for magnetic resonance imaging, comprising:
a magnetic resonance imaging probe, including:
a first electrode disposed on a distal end portion of the probe;
a second electrode disposed on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode through a reactance;
a second conductor electrically coupled to the second electrode through a reactance; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor;
an interface electrically coupled to the probe, the interface including a tuning/matching/decoupling circuit and a signal splitting circuit; and an MRI scanner electrically coupled to the interface.
[50g] According to a further aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging and ablating the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe comprises:
a first electrode disposed at least partially on a probe surface;
a second electrode disposed at least partially on the probe surface;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is - 12c-conducted between the first conductor and the second conductor, and low frequency ablating energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency ablating energy of at least one of the first electrode or the second electrode is capable of ablating the tissue;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy received at the probe.
[50h] According to another aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging the tissue and measuring a bioelectric potential in the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe has a probe surface and the probe further comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy.
150i] According to a further aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging a tissue, ablating the tissue, and measuring a bioelectric potential in the tissue, wherein the magnetic field - 12d -comprises a static component and a gradient component and wherein the probe has a probe surface and the probe further comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low-frequency and medium-frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
ablating energy is directable to the probe, the ablating energy is conductible to the tissue by at least one of the first electrode or the second electrode;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
150j) According to another aspect, there is provided a use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging and treating a tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor;
wherein a therapy is deliverable to the tissue using the probe;
- 12e-the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
[51] In an embodiment, the therapy may include at least one of ablation energy, heat, ultrasound energy, a substance discharged through a lumen of the probe, and monitoring the delivering.
BRIEF DESCRIPTION OF THE DRAWINGS
BRIEF DESCRIPTION OF THE DRAWINGS
[52] Embodiments of the disclosed systems and methods will be apparent from the following more particular description of preferred embodiments as illustrated in the accompanying drawings, in which some reference characters refer to the same parts throughout the various views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the disclosed systems and methods.
[53] FIGs. I A-1 G show physical and electrical diagrams of a probe or catheter.
[54] FIGs. 2A-21 show physical and electrical diagrams of a probe or catheter and of an interface.
[55] FIG. 3 shows a block diagram illustrating a system for magnetic resonance imaging.
[56] FIG. 4 shows data comparing the signal-to-noise ratio performance of some exemplary embodiments.
[57] FIG. 5 shows imaging and/or tracking data according to an embodiment.
[58] FIG. 6 shows imaging and/tracking data and biopotential data according to an embodiment.
DETAILED DESCRIPTION
DETAILED DESCRIPTION
[59] The disclosed systems and methods in an embodiment use MRI to allow multi-functional catheters to be placed without radiation, and provides very accurate localization of catheter tips in 3D space. With current MRI scanners, resolution is limited by the distance the RF coil is from the volume of tissue being imaged.
The signal from any particular imaging volume is picked up by an external detector coil.
The gradients select a volume inside the body for imaging, but the coil outside the body picks up the signal from the imaging volume as well as the noise from all of the sample regions that are within its range. The farther the surface coil is from the imaging volume, the more noise can be present.
The signal from any particular imaging volume is picked up by an external detector coil.
The gradients select a volume inside the body for imaging, but the coil outside the body picks up the signal from the imaging volume as well as the noise from all of the sample regions that are within its range. The farther the surface coil is from the imaging volume, the more noise can be present.
[60] MRI has been proposed as an alternative imaging modality for guiding and monitoring EP procedures and offers several advantages over other modalities for electrophysiologic intervention. For example, the heart and endocardial landmarks can be visualized throughout the procedure. This anatomical information facilitates the identification of ablation sites for arrhythmias such as atrial flutter and fibrillation.
In addition, cardiac motion and flow dynamics can be monitored during the procedure. This enables acute assessment of cardiac function as the intervention is performed. Furthermore, MRI does not employ ionizing radiation, such as x-rays, and is generally considered to be a minimal risk procedure.
In addition, cardiac motion and flow dynamics can be monitored during the procedure. This enables acute assessment of cardiac function as the intervention is performed. Furthermore, MRI does not employ ionizing radiation, such as x-rays, and is generally considered to be a minimal risk procedure.
[61] MRI can facilitate the visualization of ablated tissue during the procedure.
Because lesions are typically invisible under x-ray fluoroscopy, it is currently difficult to discern whether tissue has been completely ablated, is only temporarily stunned (i.e., has been subjected to reversible thermal injury), or indeed has not been treated at all. By actually visualizing the tissue lesion, MRI enables positive confirmation of tissue treatment. This can be especially important for procedures that benefit from continuous lines of ablation, such as treatment for atrial flutter, atrial fibrillation, and isolation of pathologic tissue in the pulmonary veins. Imaging of ablated tissue may allow what are now long and difficult procedures to be performed on a more routine and efficient basis.
Because lesions are typically invisible under x-ray fluoroscopy, it is currently difficult to discern whether tissue has been completely ablated, is only temporarily stunned (i.e., has been subjected to reversible thermal injury), or indeed has not been treated at all. By actually visualizing the tissue lesion, MRI enables positive confirmation of tissue treatment. This can be especially important for procedures that benefit from continuous lines of ablation, such as treatment for atrial flutter, atrial fibrillation, and isolation of pathologic tissue in the pulmonary veins. Imaging of ablated tissue may allow what are now long and difficult procedures to be performed on a more routine and efficient basis.
[62] In an embodiment, an internal catheter receiving coil/antenna may be incorporated into an electrophysiologic RF ablation catheter that also includes electrodes for recording bio-potentials. Because the receiving coil/antenna is closer to the imaging volume being targeted for ablation and may have a limited range of detection, the MRI signal is increased and the noise from remote regions reduced, thereby providing an enhanced signal-to-noise ratio (SNR), which enables higher strength MRI gradients to be applied, thereby improving resolution where it is needed most.
[63] In an embodiment, MRI can be used to facilitate catheter ablation of atrial fibrillation by guiding creation of continuous linear ablation lesions, and confirming that a complete linear lesion has been created (line of block) in combination with measurements of bio-potential. The visualization of areas of ablation and measurements of bio-potential may allow a reduction in the number of lesions needed, and may also reduce the number of recurrences, by more accurately ablating the arrhythmias.
[64] A reactive element can include an electrical component such as a capacitor, a resistor, an inductor, a diode, or various combinations of these. A reactive element can be a filter, such as a lowpass filter, a highpass filter, a bandpass filter, or a bandstop filter. A reactance can be a reactive element.
[65] A high frequency signal or high frequency energy can include energy that has a frequency of 10 MegaHertz (MHz) or higher. It can include energy that has a frequency of 60 MHz or higher. It can include energy that has a frequency of about 63.9 MHz.
[66] A low frequency signal or low frequency energy can include energy that has a frequency of less than 10 MHz. It can include energy that has a frequency of kiloHertz (kHz) or less. It can include energy that has a frequency of 100 kHz or less.
It can include energy that has a frequency of 1 kHz or less. It can include energy that has a frequency of 100 Hertz (Hz) or less.
It can include energy that has a frequency of 1 kHz or less. It can include energy that has a frequency of 100 Hertz (Hz) or less.
[67] Ablation frequency energy can include energy that has a frequency of less than MHz. It can include energy that has a frequency of 500 kiloHertz (kHz) or less. It can include energy that has a frequency of 100 kHz or less. It can include energy that has a frequency of 1 kHz or less. It can include energy that has a frequency of 100 10 Hertz (Hz) or less.
[68] Biopotential recording frequency energy can include energy that has a frequency of less than 10 MHz. It can include energy that has a frequency of kiloHertz (kHz) or less. It can include energy that has a frequency of 100 kHz or less.
It can include energy that has a frequency of 1 k}{z or less. It can include energy that has a frequency of 100 Hertz (Hz) or less. It can include energy that has a frequency between about 100 Hz and about I kHz.
It can include energy that has a frequency of 1 k}{z or less. It can include energy that has a frequency of 100 Hertz (Hz) or less. It can include energy that has a frequency between about 100 Hz and about I kHz.
[69] Medium frequency energy can include energy that has a frequency of less than 10 MHz and greater that 50kHz. It can include energy that has a frequency between 500 kiloHertz (kHz) and 50 kHz. It can include energy that has a frequency between 200 kHz and 50 kHz. It can include energy that has a frequency of 100 kHz.
[70] A catheter can be a probe. A probe can be a catheter.
[71] In an embodiment, a lubricious material can include at least one of polyvinylpyrrolidone, polyacrylic acid, hydrophilic substance, or silicone.
[72] FIG. IA depicts the physical structure of a probe or catheter according to an embodiment. A probe 10 can be about 10 cm to about 1000 cm long. The probe 10 can be from about 50 cm to about 200 cm long. The probe can be 100 cm long.
The probe 10 can be a catheter. The probe 10 may have two surface electrodes 14, 15.
The surface electrodes 14, 15 may be ring electrodes. The, are located at the distal end, 15, and two wire leads, 4 and 5, run the length of the catheter. The electrical structure of a conventional electrophysiology catheter is shown in FIG. lb.
Note that the electrical leads 4 and 5, terminate in respective surface electrodes, 14 and 15.
This arrangement can be less preferred for MRI studies because of (i) potential safety issues arising from heating induced in the wires and electrodes by the MRI
excitation field; (ii) application of RF energy for ablation may result in significant degradation and interference during MRI scanning; and (iii) the elements are not tuned to the MRI
frequency and generally will not provide improved SNR and MRI resolution performance. Interfering signals and noise not related to MRI detection should be limited, as should be currents induced directly in the conductors by the time-dependent MRI fields. MRI tracking may be facilitated be creating a small, confined region of high SNR.
The probe 10 can be a catheter. The probe 10 may have two surface electrodes 14, 15.
The surface electrodes 14, 15 may be ring electrodes. The, are located at the distal end, 15, and two wire leads, 4 and 5, run the length of the catheter. The electrical structure of a conventional electrophysiology catheter is shown in FIG. lb.
Note that the electrical leads 4 and 5, terminate in respective surface electrodes, 14 and 15.
This arrangement can be less preferred for MRI studies because of (i) potential safety issues arising from heating induced in the wires and electrodes by the MRI
excitation field; (ii) application of RF energy for ablation may result in significant degradation and interference during MRI scanning; and (iii) the elements are not tuned to the MRI
frequency and generally will not provide improved SNR and MRI resolution performance. Interfering signals and noise not related to MRI detection should be limited, as should be currents induced directly in the conductors by the time-dependent MRI fields. MRI tracking may be facilitated be creating a small, confined region of high SNR.
[73] It is known to those skilled in the art that long; flexible loop antennas produce local regions of high signal and are therefore ideal for active catheter tracking (For example, see Atalar E, Bottomley PA, Ocali 0, Correia LC, Kelemen MD, Lima JA, Zerhouni EA. High resolution intravascular MRI and MRS by using a catheter receiver coil. Magn Reson Med. 1996;36:596-605). For a catheter structure with two electrical leads, a loop antenna configuration can be produced by short-circuiting the distal end of the catheter. While this solution may be theoretically ideal, it is unacceptable for electrophysiology interventions because in order to perform ablation and to record of bio-potentials, multiple, electrically isolated wire leads are preferred.
[74] In an embodiment, a capacitor 20, is placed at the distal end 11, of the catheter (FIG 1c). In another preferred embodiment, in addition to the capacitor 20 at the distal end of the catheter, RF reactances 24 and 25 are applied in series with each of the surface electrodes 14 and 15, in order to improve the safety of the device for MRI
applications. The component values of the reactances 24 and 25 are adjusted or tuned such as to produce a high impedance at the MRI frequency, but low impedance at the frequency used for RF ablation and/or measuring bio-potentials. More specifically, in one embodiment, each of the reactances 24 and 25 may include a non-magnetic RF
inductor. In another preferred embodiment, each of the reactances 24 and 25 may include an RF inductor-capacitor pair, preferably non-magnetic, connected in parallel to form a parallel resonant LC circuit with resonant tuned to substantially equal to the MRI frequency, for example, 63.9 MHz with a static magnetic field of 1.5 Tesla. By this means each LC pair provides a high impedance at the MRI frequency. The LC
circuit can be formed by winding a wire coil around a ceramic chip capacitor.
For maximum effectiveness, the LC circuit should be shielded with conducting foil or the like.
applications. The component values of the reactances 24 and 25 are adjusted or tuned such as to produce a high impedance at the MRI frequency, but low impedance at the frequency used for RF ablation and/or measuring bio-potentials. More specifically, in one embodiment, each of the reactances 24 and 25 may include a non-magnetic RF
inductor. In another preferred embodiment, each of the reactances 24 and 25 may include an RF inductor-capacitor pair, preferably non-magnetic, connected in parallel to form a parallel resonant LC circuit with resonant tuned to substantially equal to the MRI frequency, for example, 63.9 MHz with a static magnetic field of 1.5 Tesla. By this means each LC pair provides a high impedance at the MRI frequency. The LC
circuit can be formed by winding a wire coil around a ceramic chip capacitor.
For maximum effectiveness, the LC circuit should be shielded with conducting foil or the like.
[75] Element 20 can also be a reactive element.
[76] To understand the function of the catheter, it is useful to consider the electrical appearance of the device at both low and high frequency ranges. First, at low frequencies, the capacitor has a large impedance and behaves approximately as an open circuit. The RF inductors have low impedance and appear as short circuits.
Therefore, the low frequency structure (FIG. 1 d) of the catheter behaves the same as the conventional structure (FIG. 1a). The electrodes can thus be used for monitoring bio-potentials, and applying RF ablation at frequencies, for example, that are lower than the MRI frequency (for example, less than about 15 MHz for RF ablation vs 63.9 MHz for MRI at 1.5 Tesla). However, at high frequencies or at the MRI
frequency, the structure is quite different. The impedance of the capacitor at high frequencies is small and is depicted as a short circuit, 21 in FIG 1 e. The RF inductors have a large impedance, behaving approximately as open circuits 34, 35. Note that the use of LC
resonant reactances 24 and 25 can provide a much higher impedance at the MRI
frequency, depending on the circuit Quality factor (Q). The net result is that rather than a two-lead catheter, the catheter now acts as a long loop MRI receiver, 40, which is ideal for tracking. Furthermore, the two catheter electrodes, 14, 15 have been decoupled from the rest of the circuit as depicted in FIG. 1 e. Note that the two electrical structures shown in FIG 1d and FIG 1e exist simultaneously, but at different frequency ranges. Therefore, this structure enables the same leads to be used for high resolution MR Imaging, the recording of physiological potentials, and/or RF
ablation.
Therefore, the low frequency structure (FIG. 1 d) of the catheter behaves the same as the conventional structure (FIG. 1a). The electrodes can thus be used for monitoring bio-potentials, and applying RF ablation at frequencies, for example, that are lower than the MRI frequency (for example, less than about 15 MHz for RF ablation vs 63.9 MHz for MRI at 1.5 Tesla). However, at high frequencies or at the MRI
frequency, the structure is quite different. The impedance of the capacitor at high frequencies is small and is depicted as a short circuit, 21 in FIG 1 e. The RF inductors have a large impedance, behaving approximately as open circuits 34, 35. Note that the use of LC
resonant reactances 24 and 25 can provide a much higher impedance at the MRI
frequency, depending on the circuit Quality factor (Q). The net result is that rather than a two-lead catheter, the catheter now acts as a long loop MRI receiver, 40, which is ideal for tracking. Furthermore, the two catheter electrodes, 14, 15 have been decoupled from the rest of the circuit as depicted in FIG. 1 e. Note that the two electrical structures shown in FIG 1d and FIG 1e exist simultaneously, but at different frequency ranges. Therefore, this structure enables the same leads to be used for high resolution MR Imaging, the recording of physiological potentials, and/or RF
ablation.
[77] In the preferred embodiment, the proximal ends 4 and 5 of the catheter are connected to an MRI tuning, matching and decoupling circuit 99 and signal splitting circuit 100 as exemplified in FIG. 2. FIG. 2a shows a photograph of the circuitry in a prototype system. In the MRI tuning, matching and decoupling circuit 99 (FIG.
2b), reactive elements 70, 71, 74, and 77 are provided such that the catheter loop 40 shown electrically in FIG. 1 e and which has an electrical inductance, is tuned to resonate at the MRI frequency when the catheter is engaged in the sample of interest such as the body. In addition, the reactive elements are adjusted so that the impedance at the catheter MRI output connections 84 and 85 is matched approximately to the characteristic impedance of the transmission cable used to connect the catheter to the receiver input of the MRI system. For example, a 50 S coaxial cable with BNC
type connectors. Alternatively, the catheter MRI output connections 84 and 85 can be connected directly to the receiver input of the MRI system, for example, to the input of a preamplifier. In this case, the impedance should be adjusted to the value that corresponds to the preamplifier input impedance that results in an optimum or near-optimum preamplifier noise figure.
2b), reactive elements 70, 71, 74, and 77 are provided such that the catheter loop 40 shown electrically in FIG. 1 e and which has an electrical inductance, is tuned to resonate at the MRI frequency when the catheter is engaged in the sample of interest such as the body. In addition, the reactive elements are adjusted so that the impedance at the catheter MRI output connections 84 and 85 is matched approximately to the characteristic impedance of the transmission cable used to connect the catheter to the receiver input of the MRI system. For example, a 50 S coaxial cable with BNC
type connectors. Alternatively, the catheter MRI output connections 84 and 85 can be connected directly to the receiver input of the MRI system, for example, to the input of a preamplifier. In this case, the impedance should be adjusted to the value that corresponds to the preamplifier input impedance that results in an optimum or near-optimum preamplifier noise figure.
[78] It will be understood that the matching circuit shown in FIG. 2b has the advantage of providing a balanced input, analogous to that provided by a balun transformer, by virtue of the two capacitors 74 and 75 connected to both sides of the catheter leads. Suitable tuning and matching circuits for catheter devices are known to those skilled in the art, for example, as described in Atalar et al cited above, and in Ocali 0, Atalar E. entitled "Intravascular magnetic resonance imaging using a loopless catheter antenna" in Magn Reson Med. 1997;37:112-8, and it will be understood that other matching and tuning circuits that are routinely used for matching and tuning MRI detector coils may be alternatively used and are within the scope of, and forseen by, the disclosed systems and methods.
[79] In addition, the MRI tuning, matching, decoupling and signal splitting circuit (FIG. 2B) shows, e.g., decoupling element 90 including a low noise PIN diode, connected across the output conductors 84 and 85. During MRI excitation by an external transmit coil, a DC bias voltage is provided by the MRI scanner across the coil input causing the PIN diode to conduct. During conduction, the tuning elements are shorted-out, which results in detuning of the catheter loop 40, and high impedance, thereby limiting those RF currents induced at the MRI frequency in the loop.
[80] In previous studies, concerns have been raised about the safety of using metallic structures in MR scanners. Radiofrequency energy (MHz) -transmitted from the scanner in order to generate the MR signal - can be deposited around the interventional device. This results in high electrical fields around the instrument and local tissue heating. This heating tends to be most concentrated at the ends of the electrical structure. This safety issue can be addressed using the disclosed systems and methods. The concern is that the surface ring electrodes, which directly contact the tissue, can cause local tissue burns. The electrodes need to be cut/removed from the circuit in the megahertz frequency range. This can be accomplished with an inductor circuit element (placed in series) between the lead wires and the surface electrodes. With this design, the electrical end of the leads (in the megahertz range) are buried inside of the catheter and as a result, the concentrated electric fields are also located inside of the catheter, instead of in the tissue. This results in a significant reduction in unwanted tissue heating. A more effective way to 'cut' the surface electrodes from the rest of the circuit could be to use a resonant circuit in place of the inductors. This resonant circuit could include an inductor in parallel with a capacitor (an 'LC circuit'). If this LC circuit is tuned to the MR
frequency, it can present a very high impedance at this frequency. This can effectively cut the surface electrodes and reduce unwanted heating. For maximal effectiveness, the LC
circuit should be shielded. The LC circuit may be placed distal to the electrodes and allowing the electrodes to be visualized.
frequency, it can present a very high impedance at this frequency. This can effectively cut the surface electrodes and reduce unwanted heating. For maximal effectiveness, the LC
circuit should be shielded. The LC circuit may be placed distal to the electrodes and allowing the electrodes to be visualized.
[81] In order to monitor physiologic bio-potentials and/or deliver RF energy for ablation, a splitting circuit is required. In FIG. 2b, leads 64 and 65 of splitting circuit 100 are connected across the catheter output leads 4 and 5. These leads are connected via RF filters 67 and 68 to either the bio-potential monitoring device and/or the RF energy source for ablation at 94 and 95. The purpose of RF
filters 67 and 68 is to prevent spurious electrical noise signals that are at least at or near the MRI frequency, from passing from either the bio-potential monitoring device or the RF energy source for ablation to the catheter system 40. In addition the RF
filters can stop RF signals induced by the MRI scanner, for example during excitation, from being input to the bio-potential monitoring device or the RF ablation energy source. The RF filters 67 and 68 can be of a number of types known to those skilled in the art, including but limited to those described in U.S. Patent No.
6,701,176, filed November 4, 1999, of which this application is a continuation in part, and in Lardo AC, McVeigh ER, Jumrussirikul P, Berger RD, Calkins H, Lima J, Halperin HR, "Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging", Circulation 2000;102:698-705.
For example, RF filters 67 and 68 can be low pass filters with a cut-off frequency chosen to lie between the MRI frequency of the catheter loop 40, and a lower RF
frequency of the RF ablation device so that any signals that arise at the MRI
frequency on lines 64 and 65 are significantly attenuated and effectively eliminated.
Alternatively, in another preferred embodiment as illustrated in FIG. 2b, filters 67 and 68 are parallel LC resonant circuits with resonant frequencies adjusted to substantially match that of the MRI frequency. By this means, the impedance of each filter can be rendered a very high value at the MRI frequency depending on the Q of the circuit, thereby stopping or substantially eliminating signals arising on lines 64, 65, 94, 95.
filters 67 and 68 is to prevent spurious electrical noise signals that are at least at or near the MRI frequency, from passing from either the bio-potential monitoring device or the RF energy source for ablation to the catheter system 40. In addition the RF
filters can stop RF signals induced by the MRI scanner, for example during excitation, from being input to the bio-potential monitoring device or the RF ablation energy source. The RF filters 67 and 68 can be of a number of types known to those skilled in the art, including but limited to those described in U.S. Patent No.
6,701,176, filed November 4, 1999, of which this application is a continuation in part, and in Lardo AC, McVeigh ER, Jumrussirikul P, Berger RD, Calkins H, Lima J, Halperin HR, "Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging", Circulation 2000;102:698-705.
For example, RF filters 67 and 68 can be low pass filters with a cut-off frequency chosen to lie between the MRI frequency of the catheter loop 40, and a lower RF
frequency of the RF ablation device so that any signals that arise at the MRI
frequency on lines 64 and 65 are significantly attenuated and effectively eliminated.
Alternatively, in another preferred embodiment as illustrated in FIG. 2b, filters 67 and 68 are parallel LC resonant circuits with resonant frequencies adjusted to substantially match that of the MRI frequency. By this means, the impedance of each filter can be rendered a very high value at the MRI frequency depending on the Q of the circuit, thereby stopping or substantially eliminating signals arising on lines 64, 65, 94, 95.
[82] In summary, it will be seen that, with the filtering and connections in place as described, low frequency physiological bio-potentials can pass unimpeded from .
surface electrodes 14 and 15 to bio-potential measuring device connected at outputs 94 and 95. Similarly RF energy for ablation applied at a frequency that is different from the MRI frequency to leads 94 and 95, can be delivered unimpeded to electrodes 14 and 15 when they are used for ablation. Any noise or other signals present at the MRI frequency can be substantially attenuated or effectively eliminated from lines 64, 65, 94, 95. From the MRI standpoint, electrodes 14 and 15 are deactivated and disconnected. The catheter behaves as a loop antenna 40 tuned to the MRI
frequency and matched to the MRI system input, 84 and 85. During MRI excitation, or in fact at any point during the procedure when it is desirable to do so, the antenna can be deactivated by a DC bias voltage applied across inputs 84, 85, by virtue of the decoupling means 90.
surface electrodes 14 and 15 to bio-potential measuring device connected at outputs 94 and 95. Similarly RF energy for ablation applied at a frequency that is different from the MRI frequency to leads 94 and 95, can be delivered unimpeded to electrodes 14 and 15 when they are used for ablation. Any noise or other signals present at the MRI frequency can be substantially attenuated or effectively eliminated from lines 64, 65, 94, 95. From the MRI standpoint, electrodes 14 and 15 are deactivated and disconnected. The catheter behaves as a loop antenna 40 tuned to the MRI
frequency and matched to the MRI system input, 84 and 85. During MRI excitation, or in fact at any point during the procedure when it is desirable to do so, the antenna can be deactivated by a DC bias voltage applied across inputs 84, 85, by virtue of the decoupling means 90.
[83] In this embodiment, it will be apparent also that the entire area of the loop antenna 40 extending from the distal portion of the catheter 11 near the electrodes, to the points where the catheter is connected to the MRI tuning, matching, decoupling and splitting circuits 99 and 100, is MRI active. However, a number of situations may arise where it is desirable to limit the length of sensitivity and/or improve the tuning properties of the loop antenna. In particular, the loop 40 is tuned by capacitor 20 in conjunction with the tuning and matching elements 71, 74, and 75 in tuning and matching circuit 99 at each end of a catheter that may be 100 cm or more long.
The extended length of this loop may render it susceptible to stray capacitance arising between the leads of the catheter, 4 and 5, and the surrounding sample and/or environment. The effect of this stray capacitance is generally to add capacitance to the effective LC resonant circuit formed by the loop antenna. If the detuhing produced by this effect is significant, it is preferably offset by re-adjustment of the tuning and matching circuit 99. Under situations where the catheter is inserted to different lengths in the sample, different amounts of stray capacitance may occur resulting in variable performance and/or a need for retuning which is not convenient during a procedure or study. In addition there are losses associated with the stray capacitances which can degrade performance as an MRI antenna.
[841 In an embodiment, the effect of the stray capacitance is reduced relative to the total capacitance needed to tune the circuit by adding additional capacitance at other locations. In order not to impede passage of bio-potential and/or RF ablation signals, the capacitors are placed between leads 4 and 5 analogous to capacitor 20. In one embodiment, depicted in FIG. 2C, tuning capacitor 20' is connected across 4 and 5 creating distal portions 4" and 5" and proximal portions 4' and 5'. The entire loop 40 is tuned to resonance via circuitry 99 as above, but now with the 2 capacitors, 20 and 20' present. In another preferred embodiment the placement of capacitor 20' is used to shorten the effective length of loop 40 to a smaller loop 40" of working length L, thereby improving MRI performance by reducing stray capacitance effects and the amount of noise picked-up from the sample. In this embodiment, a section of shielded cable, such as coaxial cable 41 may be used to form the proximal portion 40' of the loop 40. By this means, stray capacitance and noise pick-up associated with the loop section 40' is substantially eliminated. This has no effect on the measurement of bio-potentials or application of RF ablation. In yet another exemplary embodiment shown in FIG. 2d, additional capacitors 20b, 20c, 20d are connected between the catheter leads 4 and 5 to further distribute the MRI tuning capacitance along the MRI-active portion of the catheter L with shielded cable portion 41 connecting this portion to circuitry 99 and 100 described above. In an embodiment, at least one tuning capacitor is provided. In this embodiment, loop 40" is tuned as before. The number of capacitors that can be added in this way is limited by the inability to tune the circuit if the capacitance becomes too large. In addition the capacitance is preferably limited such that bio-potential and/or RF ablation signals are transmitted without significant impediment between electrodes 14 and 15, and input/output connections 94 and 95.
[85] While the catheter devices that are illustrated in FIG. 1 and FIG. 2c and FIG.
2d are depicted with two electrodes 14 and 15, this is not intended to be a limitation.
Conventional catheters with different numbers of electrodes, for example with electrodes for intra-cardiac use, are available. The multi-functional MRI
probe or catheter disclosed herein can be extended to catheters with tips with different numbers of electrodes by placing the capacitor 20 immediately proximal to the plurality of electrodes, in the case of two or more electrodes. In such embodiments, the capacitor is connected across the lead 4a that goes to the proximal electrode 15a, and to any of the leads connected to a more distal electrode such as 14b, as depicted in FIG. 2e.. A
loop antenna is thereby formed from leads 4a and 5a, which are connected to the circuitry 99 and 100 shown in FIG. 2b, as above. Because the other leads, e.g., leads 7, 8, can be used for measuring bio-potentials, and/or delivering RF energy for ablation thereby they may be filtered and each connected to a filter circuit 100. In addition, performance and safety are improved by providing reactances 24a, 24b, 25a, 25b etc, one for each electrode, of the same form and design as reactances 24 and 25 in FIG. 1 C3, IF, or 1 G.
[86] FIG. 2F depicts an embodiment in which a probe or catheter may have a single electrode, 15b. A loopless antenna, as described by and Atalar cited above, is formed by providing a shielded coaxial cable length 41" for the catheter section, with an unshielded central conductor portion extending to the single electrode 15b as shown in FIG. 2f. In this single electrode embodiment, the active or "whip" portion of the antenna extends from the electrode over the extending portion 4b, with the proximal end of 4b, and the shield of the coaxial cable fed to inputs 4 and 5 of circuits 99 and 100 shown in FIG. 2b.
[87] In an embodiment, the electrophysiology catheter can be made to function in the mode of a loopless antenna described by Ocali and Atalar cited above, with catheters employing a plurality of electrodes. In a preferred embodiment represented by FIG. lb, the distal end 4a of the catheter and distal electrode 14 form the MRI
active end of a loopless antenna, and the connecting portions 4 and 5 form a cable portion of same. In this embodiment leads 4 and 5 are preferably formed by a shielded cable section which extends from tuning/matching/decoupling/splitting circuitry 99 and 100 to proximal electrode 15, analogous to the use of cable section 41 used in FIG. 2d described above. In particular, lead 5 is formed by the outer shielding of the coaxial cable and is terminated by the ring electrode 15. The outer shielding of the coaxial cable is insulated from the sample and is only exposed to the sample at ring electrode 15. Similarly, section 4a connected to electrode 14 is electrically insulated so that it is only exposed to the sample via contact electrode 14.
Tuning of the loopless antenna via circuitry 99 is as described by Ocali and Atalar cited above, and the splitting circuitry remains unchanged. Note that in this embodiment reactive elements 23-26 may be omitted. In another embodiment, capacitor 20 may be omitted also.
[881 During MRI the conducting loops formed by electrodes 14 and 15 in loopless antenna embodiments of the disclosed systems and methods, may introduce decoupling artifacts, or give rise to local heating due to currents induced in the loops by the MRI excitation field. This problem is mainly limited to distal electrode 14 because electrode 15 is attached to the cable shield. In a further embodiment these problems are minimized by electrically cutting the circular electrodes so that they cannot make continuous loops while maintaining continuous connections between the electrode and lead 4a and 5. This will not curtail their performance for measuring bio-potentials or RF ablation. In another embodiment, these problems are minimized by reducing the diameter of the electrodes and by forming the electrodes with a solid area of conductor covering the electrode diameter.
[89] Loopless antenna embodiments have an advantage of shielding essentially the entire length of the catheter up to the proximal electrode, from stray capacitance and noise pick-up from the sample. In addition it provides the advantage of an MRI
capability with an improved range beyond the proximal electrode 15 to the most distal portion of the catheter, the distal electrode, thereby improving image quality and resolution even closer to the target area.
[90] Embodiments wherein the catheter electrodes are split to form rings as described above and which share the advantages of shielding a substantial portion of the catheter length and maximizing the imaging capability at the distal end of the catheter are further described and illustrated in FIG. 2g, 2h, and 2i. In these embodiments, the electrode rings themselves form loop antennas, and a portion of the catheter is formed by a section of coaxial cable 41", analogous to FIGS. 2d and 2f. A
tuning capacitor 20a is connected across the distal end of the coaxial cable section 41a. In this case, the value of the capacitor is chosen, in conjunction with capacitor(s) 29(a, b, etc), such as to tune the loop formed by the distal electrode(s) to resonate at the MRI frequency. One end of each split catheter ring is connected to the next electrode via capacitors, 29, 29a, 29b etc, so that the electrodes together effectively form a helical solenoid with turns that are spaced by the separation of the electrodes.
The end of the split ring of the distal electrode is connected back to the other conductor of the coaxial cable, depicted as 5b.
[91] FIG. 2G depicts a single electrode loop antenna of this form for use as a multi-functional device. FIG. 2H depicts a two-electrode device. The capacitor 29 can block low frequency currents so that bio-potentials can be measured between the electrodes without being shorted out. For RF ablation, the capacitor is chosen to have a high impedance at the RF ablation frequency, which is preferably much lower than the MRI frequency (eg, <10 MHz compared to about 64 MHz for MRI at 1.5 Tesla) to avoid interfering with MRI signals detection. Fig 2i exemplifies a four electrode device. In this case, the two center electrodes are connected via additional leads 7a, 8a, which need to be connected to filter circuitry 100, as described for FIG.
2e. In FIGS 2g, 2h, 21, reactances are preferably connected on the DC lines connecting each electrode, as in 24a, 24b, 25a, etc in FIG. 2e and described above in reference to FIG
l C3, IF, and 1 G. While these examples are described in detail some embodiments, it will be seen that this arrangement can be extended to other numbers of electrodes on the catheters, of which it is the intent of the present application to include by reference herein.
[92] The multi-functional catheter or probe systems and methods disclosed herein may be constructed so as to be fully MRI-compatible. Specifically, it's design and materials are selected such that (1) the image is not significantly distorted by the device; (2) the MRI electromagnetic fields do not alter the normal functioning of the device; (3) cardiac arrythmias or other nerve stimulation affects are not produced by the device, and (4) no damage to the tissue is produced by RF energy received from the MRI scanner. The presence of even small amounts of magnetic material in the imaging fields can produce substantial amounts of image distortion. This distortion is caused by perturbation of the imaging magnetic field. The most distortion is caused by ferromagnetic materials (iron, nickel, cobalt). Little if any distortion is produced by materials that do not become significantly magnetized (low magnetic susceptibility) by the MRI magnetic field. Metals which do not produce significant magnetization include copper, gold, platinum and aluminum among others. Many plastics and synthetic fibers are entirely non-magnetic and do not distort the images.
[93] FIG. IC shows an embodiment in which the catheter or probe is constructed based on gold-tipped, 1-15 french, most likely 7 french, MRI-compatible two-electrode ablation catheter. MRI-compatible electrode components 14 and 15, such as those used in commercial ablation catheters, or electrodes including, e.g., safe, bio-compatible, minimally corrosive materials such as gold, platinum and the like are suitable for this purpose. Leads 4 and 5 are formed from insulated conducting wire, an insulated section of flexible printed circuit board, or twin lead cable.
The conductor separation should be maintained substantially constant along the length of the catheter shaft in order to promote uniform signal sensitivity and to minimize variability in tuning, which can be accomplished by twin lead cable and flexible printed circuit board, bonding an insulated wire pair together, using a twisted pair, by a multi-lumen tube to house the electrodes, by a composite tube formed with multiple lumens for the electrodes, or by separating the pair with spacers at fixed intervals with mechanisms known in the art. The conductor leads can generally be fixed to the electrodes and/or the electrical components by standard soldering or welding techniques. Ceramic chip capacitors and (non-ferrite) RF inductors wound from small diameter copper wire are preferably used for the electrical components throughout.
[94] The shaft of the catheter is typically formed of a polymer tubing that is flexible and can be torqued within the body cavities, such as Teflon, polyolefin, polyethylene, pebax, polyurethane, or PTFE. The properties of the materials are such that they enable the device to be easily steered under MRI guidance. The diameter of the tubing should be in the range 0.8-5 mm used typically for electrophysiology procedures, or in the range 1-15 french. The total length of the catheter is in the range 0.6-2 in, but typically at least 1 m. In embodiments designed for cardiac ablation applications, the length of the invasive portion of the device is preferably at least 1.2 m long so that the tip can be placed into the heart from the femoral artery or vein, and the diameter of the device is approximately 2.5 mm. In the embodiment shown in FIG. 2c and FIG. 2d, section 41 corresponding to loop 40' can be formed from coaxial cable of diameter less than that of the shaft, and connected to circuitry 99 and 100 via standard small gauge RF-type connectors as are known and used by those skilled in the art.
[95] In the loopless antenna embodiment corresponding to FIG. lb wherein the entire proximal length of leads 4 and 5 up to electrode 15 are formed by a coaxial cable type configuration, similar coaxial cable of diameter less than that of the shaft, and connected to circuitry 99 and 100 via standard small gauge RF-type connectors can be used. Alternatively, the leads can be formed by flexible, torqueable insulated cable replacing the shaft altogether. In this version of the loopless antenna embodiment, the insulating shaft 10 (FIG. 1 a) is replaced by the external insulation on the shaft. In yet another preferred embodiment, torqueability and maneuverability are enhanced by using coaxial cable formed by a nitinol hypotube. Similarly, the shaft that forms the coaxial cable may be constructed with an inner core that is formed from nitinol, and plated with alternating layers of gold and silver. A layer of insulation made out of FEP or PET could be used to separate the inner core from the outer conductor.
[96] FIG. 3 shows a block diagram illustrating the operation of an MRI scanner system which may be used in connection with the disclosed systems and methods.
A
magnet is provided for creating the magnetic field for inducing magnetic resonance.
Within the magnet are X, Y, and Z gradient coils for producing a gradient in the static magnetic field in three orthogonal directions. Within the gradient coils is an external RF excitation coil. The external RF excitation coil produces the magnetic field to excite the MRI signals in the body. A computer is provided for controlling all components in the MRI scanner. This includes the RF frequency source, spectrometer and pulse programmer. The pulse programmer generates a carefully-controlled time-sequence of shaped and/or phase or frequency-modulated RF pulses that are delivered to the RF power amplifier. The RF power amplifier has pulse power of 1-20 kW
which is applied to the external RF excitation coil. The computer also controls the gradient magnetic field by providing a sequence of modulated pulses that are synchronous with the RF pulse sequence, to gradient power amplifiers, which in turn activate the X, Y, and Z gradient magnetic field coils in the magnet. Signals detected by receiver coils in response to the applied RF/gradient imaging sequences, including those detected in the aforementioned multi-functional MRI catheter system, are first input to a receiver preamplifier. These signals are amplified, phase sensitive detected, for example, by converting to digital signals and being fed to a digital receiver. The digital image data are then reconstructed in the computer and displayed as images on a monitor or the like.
[97] It is important that the location of the tip of the catheter can be accurately determined by MRI. A number of modes of localization can be used. Because the catheter is a receiver it can be used to directly image the tissue around it.
This image can be viewed on with high resolution employing a probe or catheter as disclosed herein, or, it can be viewed at low resolution as an overlay on a large field-of-view "scout" image obtained with an auxiliary coil outside the body. The location of the catheter in the body can be tracked by the bright line of signal moving in the scout image. The scout image can be updated at an interval set by the user to compensate for patient motion. An interactive control can allow the physician to "zoom in"
towards the bright catheter, finally resulting in a high-resolution image in the area of the distal catheter and tip. The "zoom" function can be achieved with interactive control of the imaging gradients.
[98] Some exemplary embodiments may include a combined multi-functional MRI
catheter; a multi-functional MRI catheter connected and used in conjunction with matching/tuning/decoupling circuit means and splitting circuit means; a multi-functional MRI catheter used with said circuit means in conjunction with a bio-potential monitoring device and/or a standard RF generator for use in ablation connected at inputs 94 and 95 of FIG. 2b; and any of a combined multi-functional MRI catheter and said circuit means used in conjunction with one or more of a bio-potential monitoring device, an RF generator for ablation, and an MRI scanner.
In such a system embodiment, the MRI scanner has a receiver whose inputs are connected to inputs 84 and 85.
[99] The probe or catheter disclosed herein can be used in combination with an MRI scanner such that RF energy can be delivered to selected areas of tissue with the electrodes of the multi-functional catheter, bio-potentials measured with the electrodes, the tissue imaged with the antenna portion of the catheter. RF
lesions, target tissue, catheter location and tracking may thus be visualized with the use of external detector coils or the catheter-antenna, or using external detector coils in conjunction with the catheter-antenna. This image visualization and bio-potential measurements can be used for (1) precise titration of therapy, (2) the ability to test the length and depth of lesions from new ablation-energy sources, and (3) accurate assessment of the success of making lines of ablation that block conduction.
[100] MRI can also be used to guide other procedures. In Cardiology, accurate anatomic information, combined with electrical measurements, allows improved study of the pathophysiology of arrhythmias, stunning, remodeling, and tachycardia-induced myopathy. Outside of Cardiology, MRI-guided ablation of tumors such as metastatic liver disease, brain tumors, and prostate cancer, may allow treatment with less morbidity and less cost than conventional open surgery.
[101] As an example of the embodiment depicted in FIG. 1c, a 100 cm long prototype catheter device for use in a 1.5 Tesla MRI system was constructed from electrode components taken from a gold-tipped, 7 french, MR-compatible two-electrode ablation catheter (Bard Inc., Murray Hill, New Jersey). The two wire leads were formed from 30 gauge insulated copper wire (0.25 mm wall thickness -AlphaWire Co. Elizabeth, NJ) with a conductor separation held constant at 1.3 mm.
For the shaft of the catheter, polyolefin tubing (3.36 mm diameter with 0.5 mm wall thickness - AlphaWire Co. Elizabeth, NJ) was used yielding a final catheter size of 10 french. A 500 pF chip capacitor (1.4 x 1.4 x 1.45 mm) was placed between the catheter leads 2 cm from the catheter tip (American Technical Ceramics Corp.
Huntington Station, NY). RF tip chokes 24 and 25 were not used in this implementation. This catheter was connected to circuitry shown in FIG.2b. The catheter and circuitry are pictured in FIG. 2a.
[102] Capacitors could have values in the range of about 1-1000 pF. Inductors could have values in the range of about 100-1000 nH. In an embodiment, the capacitor C
and inductor L values can be related by the equation L=1/(w2C), where w=27tB, and where B is the resonance frequency, for example, about 64 MHz.
[103] FIG. 4 shows the SNR performance of this example. SNR curve 300 represents that of a probe or catheter used as a standard electrophysiology catheter as in FIG. 1C. SNR curve 310 represents that of a probe with an open circuit such as in FIG. IB. SNR curve 320 represents that of a probe in which the loop 40 is shorted, as in FIG. IE. These data suggest that use of the example probe or catheter described above can produce a large gain in SNR compared with a standard catheter. In addition, the prototype catheter has comparable performance to the design model, FIG. 1e, which, unlike the prototype, cannot be used for electrophysiology applications.
[104] FIG. 5 exemplifies visualization and tracking of a prototype catheter.
Shown are selected images from a 10-second catheter push acquired with 10 frame/sec, real-time MRI and overlaid on a static, slice-selective roadmap image obtained with a conventional external MRI coil. The location of the catheter is readily visualized by the bright line of signal. Annotations indicate the left ventricle (LV), right ventricle (RV), chest wall, and the superior vena cava (SVC). The catheter starts in the right ventricle and is then pulled up into the right atrium (Panels a & b). As the catheter is subsequently pushed, the tip stays in the atrium and the catheter body flexes (Panel c).
The catheter is pulled back further (Panels d & e). In Panels f-g, the catheter is pushed once again, the tip stays in the right atrium, and the catheter shaft flexes. Note that the full length of the catheter can be easily visualized.
[105] FIG. 6 demonstrates the multifunctional operation of a prototype catheter, in the form of intracardiac electrograin recordings acquired concurrent with catheter tracking by MRI. Shown are selected images from a 15-second catheter push acquired with a 7 frame/sec, real-time MRI sequence. Annotations indicate the left ventricle (LV), right ventricle (RV), chest wall, and the superior vena cava (SVC).
The catheter is initially advanced from the jugular vein down the superior vena cava toward the heart (Panels a & b). Once the catheter arrives in the right atrium, the catheter tip gets stuck and the catheter body begins to flex (Panel c). The catheter is withdrawn several centimeters, the shaft is torqued, and then advanced again (Panels d & e). As the tip is now angled anteriorly, it slips through the right atrium and into the right ventricle (Panels f & g). Note that once the catheter arrives in the ventricle, a large bipolar spike is seen in the intracardiac electrogram. Bipolar endocardial recordings typically show only electrical activation of the myocardium (in the ventricle, these spikes are concurrent with the QRS complex in the body surface ECG). In Panel h, the catheter is positioned and stable in the ventricle. Note that a strong bipolar signal is recorded once the catheter tip arrives in the right ventricle (lower amplitude signal is also seen from the right atrium).
11061 MRI data can be used to construct 3D map or images of the areas in the heart or other organs being treated, that have undergone ablation, and the surrounding organ or tissue. Areas of ablation can typically be marked by elevated MRI
transverse relaxation time values (T2), or decreased longitudinal relaxation values (TI) during infusion of an MRI contrast agent wherein contrast is enhanced by alteration of such relaxation times. A composite 3D rendering of the organ being targeted can be updated after each ablation and displayed with an appropriate rendering technique. The guidance of the catheter tip to the next site of ablation and/or bio-potential measurement, can be assisted by MRI wherein the physician uses the images to manipulate and steer the catheter, or automatic tracking and feedback could assist that physician to steer the catheter. This feature is facilitated by the current availability of MRI frame rates of 10 frames/s or more, which enables real-time catheter placement, bio-potential measurements and intervention. The lesions may be visualized using standard imaging techniques including the use of contrast agents, as discussed in U.S. Patent No. 6,701,176, filed November 4, 1999, entitled "System and method for Magnetic Resonance Guided Electrophysiologic and Ablation Procedures" of which this application is a Continuation In Part.
[107] Electrical activation timing information obtained from bio-potential measurements with the catheter, when combined with catheter localization information, enables accurate activation maps that are most useful in determining, for example, the site of origin of an atrial or ventricular tachycardia in the heart.
Activation maps can be superimposed and/or color rendered on anatomically accurate reconstructions of cardiac structure. Spatially accurate voltage data is available from knowledge of the location of each electrode in contact with the myocardium in 3D, as derived from MRI. Thus, electrical data originating from each known electrode position allows generation of activation and voltage maps on true anatomic structures.
This provides significant advantages beyond the capabilities of the non-fluoroscopic electroanatomic mapping systems that do not provide accurate anatomic information.
[108] When the ablation/imaging catheter is used for the delivery of ablative radio-frequency energy, the high-resolution image obtained via the present catheter system enables visualization of the ablation lesion and of lesion growth. Again, directional orientation, as well as location, of the catheter tip can be determined in 3D
space, and the high-resolution image data can be displayed in any plane, and in particular, in the plane orthogonal to the catheter. Since the image is obtained with the same catheter that is delivering the ablative energy, the orthogonal-plane image displays the lesion at its maximal radius, reducing the chances of underestimation as often occurs with ultrasound. High-resolution visualization of ablative lesions by the multi-functional MRI catheter or probe as disclosed herein allows for documentation of whether or not RF application resulted in successful lesion development and of where lesions have and have not yet been made. This facilitates efficient catheter placement so that RF is applied only to tissue not previously ablated.
[109] The combination of the high-resolution visualization, bio-potential measurements and/or RF ablation functionality in a single catheter as discussed above makes high-resolution MRI guidance ideal for visualization and verification of ablative lesion lines, particularly in atrial tissue. This is useful for ablation of the re-entrant circuit in typical atrial flutter and is crucial for successful ablation of atrial fibrillation. It has been shown that atrial fibrillation can be eliminated with multiple lines of ablative lesions placed in the right and left atria to emulate the surgical maze procedure. Failures of the `percutaneous maze' procedure have resulted primarily from incomplete lesion lines. MRI guidance should allow rapid confirmation of lesion line continuity and avoidance of unnecessary repetition of RF application where tissue has already been successfully ablated.
[110] The MRI-guided catheter bio-potential/ablation system offers advantages in ablation of ischemic and idiopathic ventricular tachycardias, ectopic atrial tachycardiac, atrial flutter, and atrial fibrillation. Unlike AV node reentry and accessory pathway mediated tachycardia, these other arrhythmias have lower ablation success rates and longer ablation procedure durations, primarily due to difficulties in accurate activation mapping or confirmation of lesion development with conventional equipment. Procedure durations and risk of complications should thus be reduced substantially with the MRI-guided catheter ablation system.
[111] While the disclosed systems and methods have been described in connection with embodiments shown and described in detail, various modifications and improvements thereon will become readily apparent to those skilled in the art.
Accordingly, the spirit and scope of the present disclosure is limited only by the following claims.
[112] We claim:
The extended length of this loop may render it susceptible to stray capacitance arising between the leads of the catheter, 4 and 5, and the surrounding sample and/or environment. The effect of this stray capacitance is generally to add capacitance to the effective LC resonant circuit formed by the loop antenna. If the detuhing produced by this effect is significant, it is preferably offset by re-adjustment of the tuning and matching circuit 99. Under situations where the catheter is inserted to different lengths in the sample, different amounts of stray capacitance may occur resulting in variable performance and/or a need for retuning which is not convenient during a procedure or study. In addition there are losses associated with the stray capacitances which can degrade performance as an MRI antenna.
[841 In an embodiment, the effect of the stray capacitance is reduced relative to the total capacitance needed to tune the circuit by adding additional capacitance at other locations. In order not to impede passage of bio-potential and/or RF ablation signals, the capacitors are placed between leads 4 and 5 analogous to capacitor 20. In one embodiment, depicted in FIG. 2C, tuning capacitor 20' is connected across 4 and 5 creating distal portions 4" and 5" and proximal portions 4' and 5'. The entire loop 40 is tuned to resonance via circuitry 99 as above, but now with the 2 capacitors, 20 and 20' present. In another preferred embodiment the placement of capacitor 20' is used to shorten the effective length of loop 40 to a smaller loop 40" of working length L, thereby improving MRI performance by reducing stray capacitance effects and the amount of noise picked-up from the sample. In this embodiment, a section of shielded cable, such as coaxial cable 41 may be used to form the proximal portion 40' of the loop 40. By this means, stray capacitance and noise pick-up associated with the loop section 40' is substantially eliminated. This has no effect on the measurement of bio-potentials or application of RF ablation. In yet another exemplary embodiment shown in FIG. 2d, additional capacitors 20b, 20c, 20d are connected between the catheter leads 4 and 5 to further distribute the MRI tuning capacitance along the MRI-active portion of the catheter L with shielded cable portion 41 connecting this portion to circuitry 99 and 100 described above. In an embodiment, at least one tuning capacitor is provided. In this embodiment, loop 40" is tuned as before. The number of capacitors that can be added in this way is limited by the inability to tune the circuit if the capacitance becomes too large. In addition the capacitance is preferably limited such that bio-potential and/or RF ablation signals are transmitted without significant impediment between electrodes 14 and 15, and input/output connections 94 and 95.
[85] While the catheter devices that are illustrated in FIG. 1 and FIG. 2c and FIG.
2d are depicted with two electrodes 14 and 15, this is not intended to be a limitation.
Conventional catheters with different numbers of electrodes, for example with electrodes for intra-cardiac use, are available. The multi-functional MRI
probe or catheter disclosed herein can be extended to catheters with tips with different numbers of electrodes by placing the capacitor 20 immediately proximal to the plurality of electrodes, in the case of two or more electrodes. In such embodiments, the capacitor is connected across the lead 4a that goes to the proximal electrode 15a, and to any of the leads connected to a more distal electrode such as 14b, as depicted in FIG. 2e.. A
loop antenna is thereby formed from leads 4a and 5a, which are connected to the circuitry 99 and 100 shown in FIG. 2b, as above. Because the other leads, e.g., leads 7, 8, can be used for measuring bio-potentials, and/or delivering RF energy for ablation thereby they may be filtered and each connected to a filter circuit 100. In addition, performance and safety are improved by providing reactances 24a, 24b, 25a, 25b etc, one for each electrode, of the same form and design as reactances 24 and 25 in FIG. 1 C3, IF, or 1 G.
[86] FIG. 2F depicts an embodiment in which a probe or catheter may have a single electrode, 15b. A loopless antenna, as described by and Atalar cited above, is formed by providing a shielded coaxial cable length 41" for the catheter section, with an unshielded central conductor portion extending to the single electrode 15b as shown in FIG. 2f. In this single electrode embodiment, the active or "whip" portion of the antenna extends from the electrode over the extending portion 4b, with the proximal end of 4b, and the shield of the coaxial cable fed to inputs 4 and 5 of circuits 99 and 100 shown in FIG. 2b.
[87] In an embodiment, the electrophysiology catheter can be made to function in the mode of a loopless antenna described by Ocali and Atalar cited above, with catheters employing a plurality of electrodes. In a preferred embodiment represented by FIG. lb, the distal end 4a of the catheter and distal electrode 14 form the MRI
active end of a loopless antenna, and the connecting portions 4 and 5 form a cable portion of same. In this embodiment leads 4 and 5 are preferably formed by a shielded cable section which extends from tuning/matching/decoupling/splitting circuitry 99 and 100 to proximal electrode 15, analogous to the use of cable section 41 used in FIG. 2d described above. In particular, lead 5 is formed by the outer shielding of the coaxial cable and is terminated by the ring electrode 15. The outer shielding of the coaxial cable is insulated from the sample and is only exposed to the sample at ring electrode 15. Similarly, section 4a connected to electrode 14 is electrically insulated so that it is only exposed to the sample via contact electrode 14.
Tuning of the loopless antenna via circuitry 99 is as described by Ocali and Atalar cited above, and the splitting circuitry remains unchanged. Note that in this embodiment reactive elements 23-26 may be omitted. In another embodiment, capacitor 20 may be omitted also.
[881 During MRI the conducting loops formed by electrodes 14 and 15 in loopless antenna embodiments of the disclosed systems and methods, may introduce decoupling artifacts, or give rise to local heating due to currents induced in the loops by the MRI excitation field. This problem is mainly limited to distal electrode 14 because electrode 15 is attached to the cable shield. In a further embodiment these problems are minimized by electrically cutting the circular electrodes so that they cannot make continuous loops while maintaining continuous connections between the electrode and lead 4a and 5. This will not curtail their performance for measuring bio-potentials or RF ablation. In another embodiment, these problems are minimized by reducing the diameter of the electrodes and by forming the electrodes with a solid area of conductor covering the electrode diameter.
[89] Loopless antenna embodiments have an advantage of shielding essentially the entire length of the catheter up to the proximal electrode, from stray capacitance and noise pick-up from the sample. In addition it provides the advantage of an MRI
capability with an improved range beyond the proximal electrode 15 to the most distal portion of the catheter, the distal electrode, thereby improving image quality and resolution even closer to the target area.
[90] Embodiments wherein the catheter electrodes are split to form rings as described above and which share the advantages of shielding a substantial portion of the catheter length and maximizing the imaging capability at the distal end of the catheter are further described and illustrated in FIG. 2g, 2h, and 2i. In these embodiments, the electrode rings themselves form loop antennas, and a portion of the catheter is formed by a section of coaxial cable 41", analogous to FIGS. 2d and 2f. A
tuning capacitor 20a is connected across the distal end of the coaxial cable section 41a. In this case, the value of the capacitor is chosen, in conjunction with capacitor(s) 29(a, b, etc), such as to tune the loop formed by the distal electrode(s) to resonate at the MRI frequency. One end of each split catheter ring is connected to the next electrode via capacitors, 29, 29a, 29b etc, so that the electrodes together effectively form a helical solenoid with turns that are spaced by the separation of the electrodes.
The end of the split ring of the distal electrode is connected back to the other conductor of the coaxial cable, depicted as 5b.
[91] FIG. 2G depicts a single electrode loop antenna of this form for use as a multi-functional device. FIG. 2H depicts a two-electrode device. The capacitor 29 can block low frequency currents so that bio-potentials can be measured between the electrodes without being shorted out. For RF ablation, the capacitor is chosen to have a high impedance at the RF ablation frequency, which is preferably much lower than the MRI frequency (eg, <10 MHz compared to about 64 MHz for MRI at 1.5 Tesla) to avoid interfering with MRI signals detection. Fig 2i exemplifies a four electrode device. In this case, the two center electrodes are connected via additional leads 7a, 8a, which need to be connected to filter circuitry 100, as described for FIG.
2e. In FIGS 2g, 2h, 21, reactances are preferably connected on the DC lines connecting each electrode, as in 24a, 24b, 25a, etc in FIG. 2e and described above in reference to FIG
l C3, IF, and 1 G. While these examples are described in detail some embodiments, it will be seen that this arrangement can be extended to other numbers of electrodes on the catheters, of which it is the intent of the present application to include by reference herein.
[92] The multi-functional catheter or probe systems and methods disclosed herein may be constructed so as to be fully MRI-compatible. Specifically, it's design and materials are selected such that (1) the image is not significantly distorted by the device; (2) the MRI electromagnetic fields do not alter the normal functioning of the device; (3) cardiac arrythmias or other nerve stimulation affects are not produced by the device, and (4) no damage to the tissue is produced by RF energy received from the MRI scanner. The presence of even small amounts of magnetic material in the imaging fields can produce substantial amounts of image distortion. This distortion is caused by perturbation of the imaging magnetic field. The most distortion is caused by ferromagnetic materials (iron, nickel, cobalt). Little if any distortion is produced by materials that do not become significantly magnetized (low magnetic susceptibility) by the MRI magnetic field. Metals which do not produce significant magnetization include copper, gold, platinum and aluminum among others. Many plastics and synthetic fibers are entirely non-magnetic and do not distort the images.
[93] FIG. IC shows an embodiment in which the catheter or probe is constructed based on gold-tipped, 1-15 french, most likely 7 french, MRI-compatible two-electrode ablation catheter. MRI-compatible electrode components 14 and 15, such as those used in commercial ablation catheters, or electrodes including, e.g., safe, bio-compatible, minimally corrosive materials such as gold, platinum and the like are suitable for this purpose. Leads 4 and 5 are formed from insulated conducting wire, an insulated section of flexible printed circuit board, or twin lead cable.
The conductor separation should be maintained substantially constant along the length of the catheter shaft in order to promote uniform signal sensitivity and to minimize variability in tuning, which can be accomplished by twin lead cable and flexible printed circuit board, bonding an insulated wire pair together, using a twisted pair, by a multi-lumen tube to house the electrodes, by a composite tube formed with multiple lumens for the electrodes, or by separating the pair with spacers at fixed intervals with mechanisms known in the art. The conductor leads can generally be fixed to the electrodes and/or the electrical components by standard soldering or welding techniques. Ceramic chip capacitors and (non-ferrite) RF inductors wound from small diameter copper wire are preferably used for the electrical components throughout.
[94] The shaft of the catheter is typically formed of a polymer tubing that is flexible and can be torqued within the body cavities, such as Teflon, polyolefin, polyethylene, pebax, polyurethane, or PTFE. The properties of the materials are such that they enable the device to be easily steered under MRI guidance. The diameter of the tubing should be in the range 0.8-5 mm used typically for electrophysiology procedures, or in the range 1-15 french. The total length of the catheter is in the range 0.6-2 in, but typically at least 1 m. In embodiments designed for cardiac ablation applications, the length of the invasive portion of the device is preferably at least 1.2 m long so that the tip can be placed into the heart from the femoral artery or vein, and the diameter of the device is approximately 2.5 mm. In the embodiment shown in FIG. 2c and FIG. 2d, section 41 corresponding to loop 40' can be formed from coaxial cable of diameter less than that of the shaft, and connected to circuitry 99 and 100 via standard small gauge RF-type connectors as are known and used by those skilled in the art.
[95] In the loopless antenna embodiment corresponding to FIG. lb wherein the entire proximal length of leads 4 and 5 up to electrode 15 are formed by a coaxial cable type configuration, similar coaxial cable of diameter less than that of the shaft, and connected to circuitry 99 and 100 via standard small gauge RF-type connectors can be used. Alternatively, the leads can be formed by flexible, torqueable insulated cable replacing the shaft altogether. In this version of the loopless antenna embodiment, the insulating shaft 10 (FIG. 1 a) is replaced by the external insulation on the shaft. In yet another preferred embodiment, torqueability and maneuverability are enhanced by using coaxial cable formed by a nitinol hypotube. Similarly, the shaft that forms the coaxial cable may be constructed with an inner core that is formed from nitinol, and plated with alternating layers of gold and silver. A layer of insulation made out of FEP or PET could be used to separate the inner core from the outer conductor.
[96] FIG. 3 shows a block diagram illustrating the operation of an MRI scanner system which may be used in connection with the disclosed systems and methods.
A
magnet is provided for creating the magnetic field for inducing magnetic resonance.
Within the magnet are X, Y, and Z gradient coils for producing a gradient in the static magnetic field in three orthogonal directions. Within the gradient coils is an external RF excitation coil. The external RF excitation coil produces the magnetic field to excite the MRI signals in the body. A computer is provided for controlling all components in the MRI scanner. This includes the RF frequency source, spectrometer and pulse programmer. The pulse programmer generates a carefully-controlled time-sequence of shaped and/or phase or frequency-modulated RF pulses that are delivered to the RF power amplifier. The RF power amplifier has pulse power of 1-20 kW
which is applied to the external RF excitation coil. The computer also controls the gradient magnetic field by providing a sequence of modulated pulses that are synchronous with the RF pulse sequence, to gradient power amplifiers, which in turn activate the X, Y, and Z gradient magnetic field coils in the magnet. Signals detected by receiver coils in response to the applied RF/gradient imaging sequences, including those detected in the aforementioned multi-functional MRI catheter system, are first input to a receiver preamplifier. These signals are amplified, phase sensitive detected, for example, by converting to digital signals and being fed to a digital receiver. The digital image data are then reconstructed in the computer and displayed as images on a monitor or the like.
[97] It is important that the location of the tip of the catheter can be accurately determined by MRI. A number of modes of localization can be used. Because the catheter is a receiver it can be used to directly image the tissue around it.
This image can be viewed on with high resolution employing a probe or catheter as disclosed herein, or, it can be viewed at low resolution as an overlay on a large field-of-view "scout" image obtained with an auxiliary coil outside the body. The location of the catheter in the body can be tracked by the bright line of signal moving in the scout image. The scout image can be updated at an interval set by the user to compensate for patient motion. An interactive control can allow the physician to "zoom in"
towards the bright catheter, finally resulting in a high-resolution image in the area of the distal catheter and tip. The "zoom" function can be achieved with interactive control of the imaging gradients.
[98] Some exemplary embodiments may include a combined multi-functional MRI
catheter; a multi-functional MRI catheter connected and used in conjunction with matching/tuning/decoupling circuit means and splitting circuit means; a multi-functional MRI catheter used with said circuit means in conjunction with a bio-potential monitoring device and/or a standard RF generator for use in ablation connected at inputs 94 and 95 of FIG. 2b; and any of a combined multi-functional MRI catheter and said circuit means used in conjunction with one or more of a bio-potential monitoring device, an RF generator for ablation, and an MRI scanner.
In such a system embodiment, the MRI scanner has a receiver whose inputs are connected to inputs 84 and 85.
[99] The probe or catheter disclosed herein can be used in combination with an MRI scanner such that RF energy can be delivered to selected areas of tissue with the electrodes of the multi-functional catheter, bio-potentials measured with the electrodes, the tissue imaged with the antenna portion of the catheter. RF
lesions, target tissue, catheter location and tracking may thus be visualized with the use of external detector coils or the catheter-antenna, or using external detector coils in conjunction with the catheter-antenna. This image visualization and bio-potential measurements can be used for (1) precise titration of therapy, (2) the ability to test the length and depth of lesions from new ablation-energy sources, and (3) accurate assessment of the success of making lines of ablation that block conduction.
[100] MRI can also be used to guide other procedures. In Cardiology, accurate anatomic information, combined with electrical measurements, allows improved study of the pathophysiology of arrhythmias, stunning, remodeling, and tachycardia-induced myopathy. Outside of Cardiology, MRI-guided ablation of tumors such as metastatic liver disease, brain tumors, and prostate cancer, may allow treatment with less morbidity and less cost than conventional open surgery.
[101] As an example of the embodiment depicted in FIG. 1c, a 100 cm long prototype catheter device for use in a 1.5 Tesla MRI system was constructed from electrode components taken from a gold-tipped, 7 french, MR-compatible two-electrode ablation catheter (Bard Inc., Murray Hill, New Jersey). The two wire leads were formed from 30 gauge insulated copper wire (0.25 mm wall thickness -AlphaWire Co. Elizabeth, NJ) with a conductor separation held constant at 1.3 mm.
For the shaft of the catheter, polyolefin tubing (3.36 mm diameter with 0.5 mm wall thickness - AlphaWire Co. Elizabeth, NJ) was used yielding a final catheter size of 10 french. A 500 pF chip capacitor (1.4 x 1.4 x 1.45 mm) was placed between the catheter leads 2 cm from the catheter tip (American Technical Ceramics Corp.
Huntington Station, NY). RF tip chokes 24 and 25 were not used in this implementation. This catheter was connected to circuitry shown in FIG.2b. The catheter and circuitry are pictured in FIG. 2a.
[102] Capacitors could have values in the range of about 1-1000 pF. Inductors could have values in the range of about 100-1000 nH. In an embodiment, the capacitor C
and inductor L values can be related by the equation L=1/(w2C), where w=27tB, and where B is the resonance frequency, for example, about 64 MHz.
[103] FIG. 4 shows the SNR performance of this example. SNR curve 300 represents that of a probe or catheter used as a standard electrophysiology catheter as in FIG. 1C. SNR curve 310 represents that of a probe with an open circuit such as in FIG. IB. SNR curve 320 represents that of a probe in which the loop 40 is shorted, as in FIG. IE. These data suggest that use of the example probe or catheter described above can produce a large gain in SNR compared with a standard catheter. In addition, the prototype catheter has comparable performance to the design model, FIG. 1e, which, unlike the prototype, cannot be used for electrophysiology applications.
[104] FIG. 5 exemplifies visualization and tracking of a prototype catheter.
Shown are selected images from a 10-second catheter push acquired with 10 frame/sec, real-time MRI and overlaid on a static, slice-selective roadmap image obtained with a conventional external MRI coil. The location of the catheter is readily visualized by the bright line of signal. Annotations indicate the left ventricle (LV), right ventricle (RV), chest wall, and the superior vena cava (SVC). The catheter starts in the right ventricle and is then pulled up into the right atrium (Panels a & b). As the catheter is subsequently pushed, the tip stays in the atrium and the catheter body flexes (Panel c).
The catheter is pulled back further (Panels d & e). In Panels f-g, the catheter is pushed once again, the tip stays in the right atrium, and the catheter shaft flexes. Note that the full length of the catheter can be easily visualized.
[105] FIG. 6 demonstrates the multifunctional operation of a prototype catheter, in the form of intracardiac electrograin recordings acquired concurrent with catheter tracking by MRI. Shown are selected images from a 15-second catheter push acquired with a 7 frame/sec, real-time MRI sequence. Annotations indicate the left ventricle (LV), right ventricle (RV), chest wall, and the superior vena cava (SVC).
The catheter is initially advanced from the jugular vein down the superior vena cava toward the heart (Panels a & b). Once the catheter arrives in the right atrium, the catheter tip gets stuck and the catheter body begins to flex (Panel c). The catheter is withdrawn several centimeters, the shaft is torqued, and then advanced again (Panels d & e). As the tip is now angled anteriorly, it slips through the right atrium and into the right ventricle (Panels f & g). Note that once the catheter arrives in the ventricle, a large bipolar spike is seen in the intracardiac electrogram. Bipolar endocardial recordings typically show only electrical activation of the myocardium (in the ventricle, these spikes are concurrent with the QRS complex in the body surface ECG). In Panel h, the catheter is positioned and stable in the ventricle. Note that a strong bipolar signal is recorded once the catheter tip arrives in the right ventricle (lower amplitude signal is also seen from the right atrium).
11061 MRI data can be used to construct 3D map or images of the areas in the heart or other organs being treated, that have undergone ablation, and the surrounding organ or tissue. Areas of ablation can typically be marked by elevated MRI
transverse relaxation time values (T2), or decreased longitudinal relaxation values (TI) during infusion of an MRI contrast agent wherein contrast is enhanced by alteration of such relaxation times. A composite 3D rendering of the organ being targeted can be updated after each ablation and displayed with an appropriate rendering technique. The guidance of the catheter tip to the next site of ablation and/or bio-potential measurement, can be assisted by MRI wherein the physician uses the images to manipulate and steer the catheter, or automatic tracking and feedback could assist that physician to steer the catheter. This feature is facilitated by the current availability of MRI frame rates of 10 frames/s or more, which enables real-time catheter placement, bio-potential measurements and intervention. The lesions may be visualized using standard imaging techniques including the use of contrast agents, as discussed in U.S. Patent No. 6,701,176, filed November 4, 1999, entitled "System and method for Magnetic Resonance Guided Electrophysiologic and Ablation Procedures" of which this application is a Continuation In Part.
[107] Electrical activation timing information obtained from bio-potential measurements with the catheter, when combined with catheter localization information, enables accurate activation maps that are most useful in determining, for example, the site of origin of an atrial or ventricular tachycardia in the heart.
Activation maps can be superimposed and/or color rendered on anatomically accurate reconstructions of cardiac structure. Spatially accurate voltage data is available from knowledge of the location of each electrode in contact with the myocardium in 3D, as derived from MRI. Thus, electrical data originating from each known electrode position allows generation of activation and voltage maps on true anatomic structures.
This provides significant advantages beyond the capabilities of the non-fluoroscopic electroanatomic mapping systems that do not provide accurate anatomic information.
[108] When the ablation/imaging catheter is used for the delivery of ablative radio-frequency energy, the high-resolution image obtained via the present catheter system enables visualization of the ablation lesion and of lesion growth. Again, directional orientation, as well as location, of the catheter tip can be determined in 3D
space, and the high-resolution image data can be displayed in any plane, and in particular, in the plane orthogonal to the catheter. Since the image is obtained with the same catheter that is delivering the ablative energy, the orthogonal-plane image displays the lesion at its maximal radius, reducing the chances of underestimation as often occurs with ultrasound. High-resolution visualization of ablative lesions by the multi-functional MRI catheter or probe as disclosed herein allows for documentation of whether or not RF application resulted in successful lesion development and of where lesions have and have not yet been made. This facilitates efficient catheter placement so that RF is applied only to tissue not previously ablated.
[109] The combination of the high-resolution visualization, bio-potential measurements and/or RF ablation functionality in a single catheter as discussed above makes high-resolution MRI guidance ideal for visualization and verification of ablative lesion lines, particularly in atrial tissue. This is useful for ablation of the re-entrant circuit in typical atrial flutter and is crucial for successful ablation of atrial fibrillation. It has been shown that atrial fibrillation can be eliminated with multiple lines of ablative lesions placed in the right and left atria to emulate the surgical maze procedure. Failures of the `percutaneous maze' procedure have resulted primarily from incomplete lesion lines. MRI guidance should allow rapid confirmation of lesion line continuity and avoidance of unnecessary repetition of RF application where tissue has already been successfully ablated.
[110] The MRI-guided catheter bio-potential/ablation system offers advantages in ablation of ischemic and idiopathic ventricular tachycardias, ectopic atrial tachycardiac, atrial flutter, and atrial fibrillation. Unlike AV node reentry and accessory pathway mediated tachycardia, these other arrhythmias have lower ablation success rates and longer ablation procedure durations, primarily due to difficulties in accurate activation mapping or confirmation of lesion development with conventional equipment. Procedure durations and risk of complications should thus be reduced substantially with the MRI-guided catheter ablation system.
[111] While the disclosed systems and methods have been described in connection with embodiments shown and described in detail, various modifications and improvements thereon will become readily apparent to those skilled in the art.
Accordingly, the spirit and scope of the present disclosure is limited only by the following claims.
[112] We claim:
Claims (40)
1. A probe, comprising:
a matching circuit;
a first electrode residing on a distal end portion of the probe;
a second electrode residing spaced apart from the first electrode on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode and extending from the matching circuit;
a second conductor electrically coupled to the second electrode and extending from the matching circuit; and a reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor, wherein the first and second conductors and the reactive element form a loop antenna for a high frequency signal received by the probe.
a matching circuit;
a first electrode residing on a distal end portion of the probe;
a second electrode residing spaced apart from the first electrode on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode and extending from the matching circuit;
a second conductor electrically coupled to the second electrode and extending from the matching circuit; and a reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor, wherein the first and second conductors and the reactive element form a loop antenna for a high frequency signal received by the probe.
2. The probe of claim 1, wherein the reactive element is positioned to conduct a high frequency signal between the first conductor and the second conductor.
3. The probe of claim 2, wherein the reactive element is selected to conduct the high frequency signal, wherein the high frequency signal has a frequency higher than 10 MegaHertz (MHz).
4. The probe of claim 1, wherein the reactive element is positioned to conduct a signal including magnetic resonance imaging frequency energy between the first conductor and the second conductor.
5. The probe of claim 1, wherein the first conductor, second conductor, and reactive element are configured and arranged such that at least one of the first conductor and the second conductor conducts a low frequency signal to at least one of the first electrode and the second electrode.
6. The probe of claim 1, wherein the first conductor, second conductor, and reactive element are configured and arranged such that at least one of the first conductor and the second conductor conducts a low frequency signal to at least one of the first electrode and the second electrode, wherein the low frequency signal has a frequency of up to 500 kiloHertz (kHz).
7. The probe of claim 1, wherein the first conductor, second conductor, and reactive element are configured and arranged such that at least one of the first conductor and the second conductor conducts a low frequency signal to at least one of the first electrode and the second electrode, wherein the low frequency signal is in the range from 100 Hertz (Hz) to 1 kHz.
8. The probe of claim 1, wherein the first conductor, second conductor, and reactive element are configured and arranged such that at least one of the first conductor and the second conductor conducts a low frequency signal to at least one of the first electrode and the second electrode, wherein the low frequency signal is 100 kHz.
9. The probe of claim 1, wherein the reactive element is configured and arranged to conduct a signal including ablation frequency energy to at least one of the first electrode and the second electrode.
10. The probe of claim 1, wherein the reactive element is configured and arranged to conduct a signal including biopotential recording frequency energy to at least one of the first electrode or the second electrode.
11. The probe of claim 1, wherein the probe further comprises a lumen.
12. The probe of claim 1, wherein the reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, or a capacitor.
13. The probe of claim 1, wherein the first conductor couples to the first electrode through a reactance.
14. The probe of claim 13, wherein the reactance comprises at least one of an inductor or an LC circuit.
15. The probe of claim 1, wherein at least one of the first conductor, the second conductor, the first electrode, or the second electrode comprises at least one of a magnetic resonance compatible material, a superelastic material, copper, gold, silver, platinum, iridium, MP35N, tantalum, titanium, Nitinol, L605, gold-platinum-iridium, gold-copper-iridium, or gold-platinum.
16. The probe of claim 1, wherein the probe matching circuit also comprises at least one of the following:
a MRI tuning circuit; a circuit to filter out RF ablation signals; and a decoupling circuit;
and wherein the first conductor and the second conductor are electrically coupled to at least one of the tuning, filter and decoupling circuits.
a MRI tuning circuit; a circuit to filter out RF ablation signals; and a decoupling circuit;
and wherein the first conductor and the second conductor are electrically coupled to at least one of the tuning, filter and decoupling circuits.
17. The probe of claim 1, wherein the first conductor and the second conductor are electrically coupled to a signal splitting circuit.
18. The probe of claim 1, wherein the first conductor and the second conductor are also electrically coupled by at least one capacitor spaced apart from the reactive element.
19. The probe of claim 1, further comprising a third conductor electrically coupled to a third electrode, and a fourth conductor electrically coupled to a fourth electrode, wherein the first, second, third, and fourth conductors are configured and arranged so that a first signal including high frequency energy is conducted between the first conductor and the second conductor through the reactive element, and a second signal including low frequency energy is conducted to at least one of the third electrode or the fourth electrode.
20. The probe of claim 1 further comprising a shaft, the shaft including at least one of Keviar, nylon, Teflon, polyethylene, polyolefin, PTFE, polyurethane, PEBAX, braided Kevlar, or braided nylon.
21. The probe of claim 1, wherein an exterior surface of the probe is covered by a lubricious coating.
22. The probe of claim 1, wherein the probe has an outer diameter in the range of 1 French to 15 French.
23. The probe of claim 1, wherein the probe has a length in the range of 50 cm to 200 cm.
24. The probe of claim 1, wherein the probe further comprises a pull wire.
25. A magnetic resonance imaging probe, comprising:
a coaxial cable including an inner conductor and an outer shield; and a split ring electrode including a first portion and a second portion, the first portion being electrically coupled to the inner conductor, and the second portion being electrically coupled to the outer shield.
a coaxial cable including an inner conductor and an outer shield; and a split ring electrode including a first portion and a second portion, the first portion being electrically coupled to the inner conductor, and the second portion being electrically coupled to the outer shield.
26. The probe of claim 25, wherein the inner conductor and the outer shield are electrically coupled by a reactive element.
27. The probe of claim 26, wherein the reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, or a capacitor.
28. A magnetic resonance imaging probe, comprising:
a cable including an inner conductor and an outer shield;
at least one electrode electrically coupled to the inner conductor; and at least one electrode electrically coupled to the outer conductor;
wherein the at least one electrode coupled to the inner conductor and the at least one electrode coupled to the outer shield are electrically coupled by at least one reactive element.
a cable including an inner conductor and an outer shield;
at least one electrode electrically coupled to the inner conductor; and at least one electrode electrically coupled to the outer conductor;
wherein the at least one electrode coupled to the inner conductor and the at least one electrode coupled to the outer shield are electrically coupled by at least one reactive element.
29. The probe of claim 28, wherein the inner conductor and the outer shield are electrically coupled by a plurality of spaced apart reactive elements.
30. The probe of claim 29, wherein at least one of the plurality of reactive elements comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, or a capacitor.
31. The probe of claim 28, wherein at least one of the at least one reactive element comprises at least one of a high-pass filter, a low-pass filter, a band-pass filter, or a capacitor residing at a distal end portion of the probe, and wherein the at least one electrode coupled to the inner conductor and the at least one electrode coupled to the outer shield each comprise a split ring electrode.
32. A magnetic resonance imaging probe, comprising:
a coaxial cable including an inner conductor and an outer shield;
a first split ring electrode electrically coupled to the inner conductor; and a second split ring electrode electrically coupled to the outer shield;
a first center split ring electrode electrically coupled to the first split ring electrode and to a first conductor;
a second center split ring electrode electrically coupled to the first center split ring electrode and to the second split ring electrode, and also coupled to a second conductor.
a coaxial cable including an inner conductor and an outer shield;
a first split ring electrode electrically coupled to the inner conductor; and a second split ring electrode electrically coupled to the outer shield;
a first center split ring electrode electrically coupled to the first split ring electrode and to a first conductor;
a second center split ring electrode electrically coupled to the first center split ring electrode and to the second split ring electrode, and also coupled to a second conductor.
33. A magnetic resonance imaging probe, comprising:
a matching circuit;
a first electrode disposed on a probe surface;
a second electrode disposed on the probe surface;
a first conductor extending from the matching circuit and electrically coupled to the first electrode through a reactance;
a second conductor extending from the matching circuit and electrically coupled to the second electrode through a reactance; and a frequency-dependent reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor to form a loop antenna.
a matching circuit;
a first electrode disposed on a probe surface;
a second electrode disposed on the probe surface;
a first conductor extending from the matching circuit and electrically coupled to the first electrode through a reactance;
a second conductor extending from the matching circuit and electrically coupled to the second electrode through a reactance; and a frequency-dependent reactive element disposed between the matching circuit and a distal end of the probe, the reactive element electrically coupling the first conductor and the second conductor such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor to form a loop antenna.
34. A system for magnetic resonance imaging, comprising:
a magnetic resonance imaging probe, including:
a first electrode disposed on a distal end portion of the probe;
a second electrode disposed on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode through a reactance;
a second conductor electrically coupled to the second electrode through a reactance; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor;
an interface electrically coupled to the probe, the interface including a tuning/matching/decoupling circuit and a signal splitting circuit; and an MRI scanner electrically coupled to the interface.
a magnetic resonance imaging probe, including:
a first electrode disposed on a distal end portion of the probe;
a second electrode disposed on the distal end portion of the probe;
a first conductor electrically coupled to the first electrode through a reactance;
a second conductor electrically coupled to the second electrode through a reactance; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy received by the probe is conducted between the first conductor and the second conductor;
an interface electrically coupled to the probe, the interface including a tuning/matching/decoupling circuit and a signal splitting circuit; and an MRI scanner electrically coupled to the interface.
35. Use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging and ablating the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe comprises:
a first electrode disposed at least partially on a probe surface;
a second electrode disposed at least partially on the probe surface;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency ablating energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency ablating energy of at least one of the first electrode or the second electrode is capable of ablating the tissue;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy received at the probe.
a first electrode disposed at least partially on a probe surface;
a second electrode disposed at least partially on the probe surface;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency ablating energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency ablating energy of at least one of the first electrode or the second electrode is capable of ablating the tissue;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy received at the probe.
36. Use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging the tissue and measuring a bioelectric potential in the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe has a probe surface and the probe further comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy.
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy.
37. Use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging a tissue, ablating the tissue, and measuring a bioelectric potential in the tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe has a probe surface and the probe further comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low-frequency and medium-frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
ablating energy is directable to the probe, the ablating energy is conductible to the tissue by at least one of the- first electrode or the second electrode;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor, and low-frequency and medium-frequency energy is conducted to at least one of the first electrode or the second electrode;
wherein the low frequency energy is conductible from at least one of the first electrode or the second electrode and a bioelectric potential is measurable in the tissue based on the low-frequency energy received from the probe;
ablating energy is directable to the probe, the ablating energy is conductible to the tissue by at least one of the- first electrode or the second electrode;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
38. Use of a probe adjacent to a tissue and a magnetic field exposable to the tissue for imaging and treating a tissue, wherein the magnetic field comprises a static component and a gradient component and wherein the probe comprises:
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor;
wherein a therapy is deliverable to the tissue using the probe;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
a first electrode;
a second electrode;
a first conductor electrically coupled to the first electrode;
a second conductor electrically coupled to the second electrode; and a frequency-dependent reactive element electrically coupling the first conductor and the second conductor, such that high-frequency energy is conducted between the first conductor and the second conductor;
wherein a therapy is deliverable to the tissue using the probe;
the high frequency energy is receivable at the probe using the first conductor, the second conductor, and the reactive element as an antenna; and the tissue is imageable using the high-frequency energy from the probe, the high-frequency energy from the probe having magnetic resonance imaging data.
39. The use of claim 38, wherein the deliverable therapy comprises at least one of ablation energy, heat, ultrasound energy, or a substance discharged through a lumen of the probe, and wherein the therapy is deliverable and the tissue is imageable substantially simultaneously.
40. The use of claim 39, wherein the therapy that is deliverable, is monitorable using images based on data from the probe.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28372501P | 2001-04-13 | 2001-04-13 | |
US60/283,725 | 2001-04-13 | ||
PCT/US2002/011984 WO2002083016A1 (en) | 2001-04-13 | 2002-04-15 | Systems and methods for magnetic-resonance-guided interventional procedures |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2482202A1 CA2482202A1 (en) | 2002-10-24 |
CA2482202C true CA2482202C (en) | 2012-07-03 |
Family
ID=23087285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2482202A Expired - Lifetime CA2482202C (en) | 2001-04-13 | 2002-04-15 | Systems and methods for magnetic-resonance-guided interventional procedures |
Country Status (3)
Country | Link |
---|---|
US (2) | US7689288B2 (en) |
CA (1) | CA2482202C (en) |
WO (1) | WO2002083016A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8979871B2 (en) | 2009-08-13 | 2015-03-17 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9333038B2 (en) | 2000-06-15 | 2016-05-10 | Monteris Medical Corporation | Hyperthermia treatment and probe therefore |
US9433383B2 (en) | 2014-03-18 | 2016-09-06 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9504484B2 (en) | 2014-03-18 | 2016-11-29 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US10327830B2 (en) | 2015-04-01 | 2019-06-25 | Monteris Medical Corporation | Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor |
US10675113B2 (en) | 2014-03-18 | 2020-06-09 | Monteris Medical Corporation | Automated therapy of a three-dimensional tissue region |
Families Citing this family (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9061139B2 (en) | 1998-11-04 | 2015-06-23 | Greatbatch Ltd. | Implantable lead with a band stop filter having a capacitor in parallel with an inductor embedded in a dielectric body |
US6701176B1 (en) | 1998-11-04 | 2004-03-02 | Johns Hopkins University School Of Medicine | Magnetic-resonance-guided imaging, electrophysiology, and ablation |
US8244370B2 (en) | 2001-04-13 | 2012-08-14 | Greatbatch Ltd. | Band stop filter employing a capacitor and an inductor tank circuit to enhance MRI compatibility of active medical devices |
CA2468252A1 (en) * | 2000-11-20 | 2002-05-23 | Surgi-Vision, Inc. | Connector and guidewire connectable thereto |
US7853325B2 (en) | 2001-04-13 | 2010-12-14 | Greatbatch Ltd. | Cylindrical bandstop filters for medical lead systems |
US20070088416A1 (en) | 2001-04-13 | 2007-04-19 | Surgi-Vision, Inc. | Mri compatible medical leads |
US8437865B2 (en) * | 2001-04-13 | 2013-05-07 | Greatbatch Ltd. | Shielded network for an active medical device implantable lead |
US7899551B2 (en) | 2001-04-13 | 2011-03-01 | Greatbatch Ltd. | Medical lead system utilizing electromagnetic bandstop filters |
US8989870B2 (en) | 2001-04-13 | 2015-03-24 | Greatbatch Ltd. | Tuned energy balanced system for minimizing heating and/or to provide EMI protection of implanted leads in a high power electromagnetic field environment |
US8219208B2 (en) * | 2001-04-13 | 2012-07-10 | Greatbatch Ltd. | Frequency selective passive component networks for active implantable medical devices utilizing an energy dissipating surface |
US8977355B2 (en) | 2001-04-13 | 2015-03-10 | Greatbatch Ltd. | EMI filter employing a capacitor and an inductor tank circuit having optimum component values |
US9295828B2 (en) | 2001-04-13 | 2016-03-29 | Greatbatch Ltd. | Self-resonant inductor wound portion of an implantable lead for enhanced MRI compatibility of active implantable medical devices |
US8509913B2 (en) * | 2001-04-13 | 2013-08-13 | Greatbatch Ltd. | Switched diverter circuits for minimizing heating of an implanted lead and/or providing EMI protection in a high power electromagnetic field environment |
US8457760B2 (en) | 2001-04-13 | 2013-06-04 | Greatbatch Ltd. | Switched diverter circuits for minimizing heating of an implanted lead and/or providing EMI protection in a high power electromagnetic field environment |
US7787958B2 (en) | 2001-04-13 | 2010-08-31 | Greatbatch Ltd. | RFID detection and identification system for implantable medical lead systems |
WO2002083016A1 (en) | 2001-04-13 | 2002-10-24 | Surgi-Vision, Inc. | Systems and methods for magnetic-resonance-guided interventional procedures |
US8712544B2 (en) | 2001-04-13 | 2014-04-29 | Greatbatch Ltd. | Electromagnetic shield for a passive electronic component in an active medical device implantable lead |
US8000801B2 (en) * | 2001-04-13 | 2011-08-16 | Greatbatch Ltd. | System for terminating abandoned implanted leads to minimize heating in high power electromagnetic field environments |
US8396568B2 (en) * | 2002-04-11 | 2013-03-12 | Medtronic, Inc. | Medical electrical lead body designs incorporating energy dissipating shunt |
US6904307B2 (en) | 2002-05-29 | 2005-06-07 | Surgi-Vision, Inc. | Magnetic resonance probes |
US8108028B2 (en) * | 2004-07-27 | 2012-01-31 | Surgi-Vision Inc. | MRI systems having MRI compatible universal delivery cannulas with cooperating MRI antenna probes and related systems and methods |
US8874228B2 (en) | 2004-07-27 | 2014-10-28 | The Cleveland Clinic Foundation | Integrated system and method for MRI-safe implantable devices |
US8509876B2 (en) | 2004-08-09 | 2013-08-13 | The Johns Hopkins University | Implantable MRI compatible stimulation leads and antennas and related systems and methods |
CA2606824C (en) * | 2005-05-04 | 2015-11-24 | Surgi-Vision, Inc. | Improved electrical lead for an electronic device such as an implantable device |
WO2007008301A2 (en) * | 2005-07-12 | 2007-01-18 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
AU2006304775B2 (en) | 2005-10-21 | 2011-11-17 | Boston Scientific Neuromodulation Corporation | MRI-safe high impedance lead systems and related methods |
EP2392382A1 (en) * | 2005-11-11 | 2011-12-07 | Greatbatch Ltd. | Tank filters placed in series with the lead wires or circuits of active medical devices to enhance MRI compatibility |
US8224462B2 (en) | 2005-11-11 | 2012-07-17 | Greatbatch Ltd. | Medical lead system utilizing electromagnetic bandstop filters |
JP2009514617A (en) | 2005-11-11 | 2009-04-09 | グレートバッチ リミテッド | Tank filter placed in series with active medical device lead wires or circuitry to enhance MRI compatibility |
US7702387B2 (en) | 2006-06-08 | 2010-04-20 | Greatbatch Ltd. | Tank filters adaptable for placement with a guide wire, in series with the lead wires or circuits of active medical devices to enhance MRI compatibility |
US8903505B2 (en) | 2006-06-08 | 2014-12-02 | Greatbatch Ltd. | Implantable lead bandstop filter employing an inductive coil with parasitic capacitance to enhance MRI compatibility of active medical devices |
US9042999B2 (en) | 2006-06-08 | 2015-05-26 | Greatbatch Ltd. | Low loss band pass filter for RF distance telemetry pin antennas of active implantable medical devices |
US8116862B2 (en) | 2006-06-08 | 2012-02-14 | Greatbatch Ltd. | Tank filters placed in series with the lead wires or circuits of active medical devices to enhance MRI compatibility |
CN101495881B (en) * | 2006-08-02 | 2013-05-01 | 皇家飞利浦电子股份有限公司 | Transmission path for use in RF fields |
CN101505672B (en) * | 2006-08-22 | 2012-02-08 | 皇家飞利浦电子股份有限公司 | Interventional device for RF ablation for use in RF fields |
US9468750B2 (en) | 2006-11-09 | 2016-10-18 | Greatbatch Ltd. | Multilayer planar spiral inductor filter for medical therapeutic or diagnostic applications |
US9031670B2 (en) | 2006-11-09 | 2015-05-12 | Greatbatch Ltd. | Electromagnetic shield for a passive electronic component in an active medical device implantable lead |
US7831076B2 (en) * | 2006-12-08 | 2010-11-09 | Biosense Webster, Inc. | Coloring electroanatomical maps to indicate ultrasound data acquisition |
AU2013251245B2 (en) * | 2006-12-08 | 2015-05-14 | Biosense Webster, Inc. | Coloring electroanatomical maps to indicate ultrasound data acquisition |
JP5568315B2 (en) * | 2007-03-19 | 2014-08-06 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | RF / MRI compatible lead wire |
EP2705874B1 (en) * | 2007-03-19 | 2016-09-28 | Boston Scientific Neuromodulation Corporation | MRI and RF compatible leads |
US20090234368A1 (en) * | 2008-03-17 | 2009-09-17 | Brian Gore | Low profile medical devices with internal drive shafts that cooperate with releasably engageable drive tools and related methods |
US10080889B2 (en) | 2009-03-19 | 2018-09-25 | Greatbatch Ltd. | Low inductance and low resistance hermetically sealed filtered feedthrough for an AIMD |
US9108066B2 (en) | 2008-03-20 | 2015-08-18 | Greatbatch Ltd. | Low impedance oxide resistant grounded capacitor for an AIMD |
US8483840B2 (en) * | 2008-03-20 | 2013-07-09 | Greatbatch Ltd. | Dual function tuned L-C input trap passive EMI filter component network for an active implantable medical device |
WO2009134901A1 (en) * | 2008-04-30 | 2009-11-05 | Medtronic, Inc. | Magnetic resonance imaging shunt electrodes with self-healing coatings |
EP2349453A4 (en) | 2008-10-30 | 2015-07-01 | Greatbatch Ltd | Capacitor and inductor elements physically disposed in series whose lumped parameters are electrically connected in parallel to form a bandstop filter |
US8996126B2 (en) | 2009-02-04 | 2015-03-31 | Greatbatch Ltd. | Composite RF current attenuator for a medical lead |
US8843213B2 (en) | 2009-03-04 | 2014-09-23 | Imricor Medical Systems, Inc. | MRI compatible co-radially wound lead assembly |
US8831743B2 (en) | 2009-03-04 | 2014-09-09 | Imricor Medical Systems, Inc. | MRI compatible electrode circuit |
US8805540B2 (en) * | 2009-03-04 | 2014-08-12 | Imricor Medical Systems, Inc. | MRI compatible cable |
CN102341037B (en) * | 2009-03-04 | 2014-11-26 | 艾姆瑞科医疗系统有限公司 | MRI compatible electrode circuit |
US8855788B2 (en) | 2009-03-04 | 2014-10-07 | Imricor Medical Systems, Inc. | MRI compatible electrode circuit |
US8761899B2 (en) | 2009-03-04 | 2014-06-24 | Imricor Medical Systems, Inc. | MRI compatible conductive wires |
US20120256704A1 (en) | 2011-03-01 | 2012-10-11 | Greatbatch Ltd. | Rf filter for an active medical device (amd) for handling high rf power induced in an associated implanted lead from an external rf field |
US8095224B2 (en) | 2009-03-19 | 2012-01-10 | Greatbatch Ltd. | EMI shielded conduit assembly for an active implantable medical device |
DE102009001984A1 (en) * | 2009-03-30 | 2010-10-14 | Bruker Biospin Ag | Device for monitoring a living being during a magnetic resonance experiment |
DE102009002152A1 (en) | 2009-04-02 | 2010-12-02 | Biotronik Crm Patent Ag | Stimulation electrode lead |
US9439735B2 (en) | 2009-06-08 | 2016-09-13 | MRI Interventions, Inc. | MRI-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time |
US8396532B2 (en) | 2009-06-16 | 2013-03-12 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US8554338B2 (en) * | 2009-11-05 | 2013-10-08 | Pacesetter, Inc. | MRI-compatible implantable lead having a heat spreader and method of using same |
US9014815B2 (en) * | 2009-11-19 | 2015-04-21 | Medtronic, Inc. | Electrode assembly in a medical electrical lead |
US20110144722A1 (en) * | 2009-12-10 | 2011-06-16 | Pacesetter, Inc. | Mri-compatible implantable lead with improved lc resonant component |
US20110152990A1 (en) * | 2009-12-22 | 2011-06-23 | Pacesetter, Inc. | Mri compatible lead employing multiple miniature inductors |
US8882763B2 (en) | 2010-01-12 | 2014-11-11 | Greatbatch Ltd. | Patient attached bonding strap for energy dissipation from a probe or a catheter during magnetic resonance imaging |
US8380322B2 (en) * | 2010-02-11 | 2013-02-19 | Biotronik Crm Patent Ag | Electrode device for active medical implants |
US9126031B2 (en) | 2010-04-30 | 2015-09-08 | Medtronic, Inc. | Medical electrical lead with conductive sleeve head |
EP4116729A1 (en) * | 2010-10-06 | 2023-01-11 | Aspect Imaging Ltd. | Method for fusing mr images |
US8977368B2 (en) * | 2010-12-17 | 2015-03-10 | Biotronik Se & Co. Kg | Implantable device |
US10596369B2 (en) | 2011-03-01 | 2020-03-24 | Greatbatch Ltd. | Low equivalent series resistance RF filter for an active implantable medical device |
US9757558B2 (en) | 2011-03-01 | 2017-09-12 | Greatbatch Ltd. | RF filter for an active medical device (AMD) for handling high RF power induced in an associated implanted lead from an external RF field |
US11198014B2 (en) | 2011-03-01 | 2021-12-14 | Greatbatch Ltd. | Hermetically sealed filtered feedthrough assembly having a capacitor with an oxide resistant electrical connection to an active implantable medical device housing |
US10350421B2 (en) | 2013-06-30 | 2019-07-16 | Greatbatch Ltd. | Metallurgically bonded gold pocket pad for grounding an EMI filter to a hermetic terminal for an active implantable medical device |
US9427596B2 (en) | 2013-01-16 | 2016-08-30 | Greatbatch Ltd. | Low impedance oxide resistant grounded capacitor for an AIMD |
US9931514B2 (en) | 2013-06-30 | 2018-04-03 | Greatbatch Ltd. | Low impedance oxide resistant grounded capacitor for an AIMD |
US10272252B2 (en) | 2016-11-08 | 2019-04-30 | Greatbatch Ltd. | Hermetic terminal for an AIMD having a composite brazed conductive lead |
EP2537553B1 (en) | 2011-06-21 | 2013-08-28 | Sorin CRM SAS | Probe for implantable cardiac prosthesis, comprising a built-in means for protection against the effects of MRI fields |
US9504843B2 (en) | 2011-08-19 | 2016-11-29 | Greatbach Ltd. | Implantable cardioverter defibrillator designed for use in a magnetic resonance imaging environment |
US20130116765A1 (en) * | 2011-11-07 | 2013-05-09 | Oscor Inc. | Implantable lead adaptor with mri filter |
EP2594314A1 (en) | 2011-11-17 | 2013-05-22 | Greatbatch Ltd. | Composite RF attenuator for a medical lead |
US9345895B2 (en) | 2012-04-26 | 2016-05-24 | Medtronic, Inc. | Implantable medical device and feedthrough and method of making same |
US9093974B2 (en) | 2012-09-05 | 2015-07-28 | Avx Corporation | Electromagnetic interference filter for implanted electronics |
US20140114381A1 (en) | 2012-10-23 | 2014-04-24 | Medtronic, Inc. | Mr-compatible implantable medical lead |
USRE46699E1 (en) | 2013-01-16 | 2018-02-06 | Greatbatch Ltd. | Low impedance oxide resistant grounded capacitor for an AIMD |
RU2623684C2 (en) * | 2013-05-03 | 2017-06-28 | 3М Инновейтив Пропертиз Компани | System for monitoring temperature of electrical conductors |
US9788641B2 (en) * | 2014-02-12 | 2017-10-17 | Lenovo (Singapore) Pte. Ltd. | Activity powered band device |
EP3143421A4 (en) | 2014-05-13 | 2018-04-04 | Aspect Imaging Ltd. | Protective and immobilizing sleeves with sensors, and methods for reducing the effect of object movement during MRI scanning |
US20160077169A1 (en) * | 2014-09-15 | 2016-03-17 | The General Hospital Corporation | System and Method for Coordinating Use of An Interventional or Implantable Device With External Magnetic Fields |
JP2018504154A (en) * | 2014-12-03 | 2018-02-15 | カーディオフォーカス,インコーポレーテッド | System and method for visual confirmation of pulmonary vein isolation during ablation procedures |
EP3081258A1 (en) | 2015-04-16 | 2016-10-19 | Greatbatch Ltd. | Rf filter for an active medical device (amd) for handling high rf power induced in an associated implanted lead from an external rf field |
US10363425B2 (en) | 2015-06-01 | 2019-07-30 | Avx Corporation | Discrete cofired feedthrough filter for medical implanted devices |
US10249415B2 (en) | 2017-01-06 | 2019-04-02 | Greatbatch Ltd. | Process for manufacturing a leadless feedthrough for an active implantable medical device |
WO2018189226A1 (en) * | 2017-04-11 | 2018-10-18 | Enraf-Nonius B.V. | Electrical device comprising filter and feedthrough capacitor |
KR101813558B1 (en) * | 2017-04-12 | 2018-01-03 | 주식회사 서린메디케어 | Skin treatment apparatus using fractional plasma |
US20190117969A1 (en) * | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Medical devices for treatment of cancer with electric fields |
US11338135B2 (en) | 2017-10-23 | 2022-05-24 | Cardiac Pacemakers, Inc. | Medical devices for cancer therapy with electric field shaping elements |
US10874865B2 (en) | 2017-11-06 | 2020-12-29 | Avx Corporation | EMI feedthrough filter terminal assembly containing a resin coating over a hermetically sealing material |
DE102018102965A1 (en) * | 2018-02-09 | 2019-08-14 | Otto-Von-Guericke-Universität Magdeburg | Hybrid system for performing magnetic resonance imaging and radiofrequency ablation and method of operation |
DE102019106675A1 (en) | 2018-03-20 | 2019-09-26 | Biotronik Se & Co. Kg | Lead for a medical implant, with integrated periodic induction coils (iPIC) for reduced interactions with electromagnetic fields |
US10905888B2 (en) | 2018-03-22 | 2021-02-02 | Greatbatch Ltd. | Electrical connection for an AIMD EMI filter utilizing an anisotropic conductive layer |
US10912945B2 (en) | 2018-03-22 | 2021-02-09 | Greatbatch Ltd. | Hermetic terminal for an active implantable medical device having a feedthrough capacitor partially overhanging a ferrule for high effective capacitance area |
CN109947104B (en) * | 2019-03-27 | 2021-12-21 | 河海大学常州校区 | Automatic tracking method for unilateral roundabout |
JP7410176B2 (en) | 2019-04-22 | 2024-01-09 | ボストン サイエンティフィック サイムド,インコーポレイテッド | System for delivering electrical stimulation to treat cancer |
CN113727753A (en) | 2019-04-22 | 2021-11-30 | 波士顿科学国际有限公司 | Electrical stimulation device for cancer treatment |
JP2022529374A (en) | 2019-04-23 | 2022-06-21 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Electrodes for electrical stimulation for cancer treatment |
US11607542B2 (en) | 2019-04-23 | 2023-03-21 | Boston Scientific Scimed, Inc. | Electrical stimulation for cancer treatment with internal and external electrodes |
EP3958960A1 (en) | 2019-04-23 | 2022-03-02 | Boston Scientific Scimed Inc. | Electrical stimulation with thermal treatment or thermal monitoring |
CN110531611B (en) * | 2019-05-30 | 2022-12-06 | 哈尔滨工业大学(深圳) | Ultrasonic bonding frequency tracking method based on PSO algorithm and PID control |
CN115515674A (en) | 2020-02-24 | 2022-12-23 | 波士顿科学国际有限公司 | Systems and methods for treating pancreatic cancer |
EP4302819A1 (en) * | 2022-07-07 | 2024-01-10 | BIOTRONIK SE & Co. KG | A paddle lead |
Family Cites Families (362)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3871382A (en) | 1973-02-15 | 1975-03-18 | Pacesetter Syst | Heart stimulator system for rapid implantation and removal with improved integrity |
US3968802A (en) | 1975-01-24 | 1976-07-13 | Medtronic, Inc. | Cautery protection circuit for a heart pacemaker |
US3980975A (en) | 1975-09-08 | 1976-09-14 | Varian Associates | Broadband microwave bias network |
US4236127A (en) | 1977-04-13 | 1980-11-25 | Pyrohm, Inc. | Electrical frequency responsive structure |
US4188598A (en) | 1977-11-07 | 1980-02-12 | Hunt Morris C | Electrical filter |
US4295467A (en) | 1979-05-24 | 1981-10-20 | Inverness International Corp. | Electrolysis apparatus with retractable probe |
US4320763A (en) | 1979-10-10 | 1982-03-23 | Telectronics Pty. Limited | Protection device for pacemaker implantees |
US4445501A (en) | 1981-05-07 | 1984-05-01 | Mccormick Laboratories, Inc. | Circuits for determining very accurately the position of a device inside biological tissue |
US4431005A (en) | 1981-05-07 | 1984-02-14 | Mccormick Laboratories, Inc. | Method of and apparatus for determining very accurately the position of a device inside biological tissue |
US4424551B1 (en) | 1982-01-25 | 1991-06-11 | Highly-reliable feed through/filter capacitor and method for making same | |
US4437474A (en) | 1982-07-16 | 1984-03-20 | Cordis Corporation | Method for making multiconductor coil and the coil made thereby |
US4585001A (en) | 1982-09-28 | 1986-04-29 | Norland Corporation | Cardiac pacer signal detector |
US4633181A (en) | 1983-08-11 | 1986-12-30 | Regents Of The University Of Calif. | Apparatus and method for increasing the sensitivity of a nuclear magnetic resonance probe |
US4654880A (en) | 1983-12-09 | 1987-03-31 | Minnesota Mining And Manufacturing Company | Signal transmission system |
CA1226624A (en) | 1983-12-09 | 1987-09-08 | Minnesota Mining And Manufacturing Company | Signal transmission system |
JPS60141034U (en) | 1984-02-29 | 1985-09-18 | カシオ計算機株式会社 | keyboard |
US4572198A (en) | 1984-06-18 | 1986-02-25 | Varian Associates, Inc. | Catheter for use with NMR imaging systems |
DE3429386A1 (en) | 1984-08-09 | 1986-02-27 | Siemens AG, 1000 Berlin und 8000 München | MAIN SPIN TOMOGRAPHY UNIT |
US4672972A (en) | 1984-08-13 | 1987-06-16 | Berke Howard R | Solid state NMR probe |
US4686988A (en) | 1984-10-19 | 1987-08-18 | Sholder Jason A | Pacemaker system and method for measuring and monitoring cardiac activity and for determining and maintaining capture |
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
JPS61209643A (en) | 1985-03-15 | 1986-09-17 | 株式会社東芝 | Ultrasonic diagnostic and medical treatment apparatus |
JPS61181925U (en) | 1985-05-07 | 1986-11-13 | ||
US5209233A (en) | 1985-08-09 | 1993-05-11 | Picker International, Inc. | Temperature sensing and control system for cardiac monitoring electrodes |
DE3529578A1 (en) | 1985-08-17 | 1987-02-19 | Bisping Hans Juergen | IMPLANTABLE ELECTRODE |
US4643186A (en) | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
GB8600665D0 (en) | 1986-01-13 | 1986-02-19 | Longmore D B | Surgical catheters |
US4689621A (en) | 1986-03-31 | 1987-08-25 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Temperature responsive transmitter |
JPH0763455B2 (en) | 1986-03-31 | 1995-07-12 | 株式会社東芝 | Magnetic resonance imager |
IL78755A0 (en) | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Applicator for insertion into a body opening for medical purposes |
IL78756A0 (en) | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Catheter and probe |
US4788980A (en) | 1986-07-18 | 1988-12-06 | Siemens-Pacesetter, Inc. | Pacemaker having PVC response and PMT terminating features |
US5251120A (en) | 1986-07-23 | 1993-10-05 | Steve Smith | Harmonic noise isolation and power factor correction network |
US4754752A (en) | 1986-07-28 | 1988-07-05 | Robert Ginsburg | Vascular catheter |
US4960106A (en) | 1987-04-28 | 1990-10-02 | Olympus Optical Co., Ltd. | Endoscope apparatus |
IL82658A (en) | 1987-05-26 | 1990-12-23 | Elscint Ltd | Balun circuit for radio frequency coils in mr systems |
US4832023A (en) | 1987-06-03 | 1989-05-23 | Mcm Laboratories, Inc. | Method and apparatus for reducing blockage in body channels |
US4989608A (en) | 1987-07-02 | 1991-02-05 | Ratner Adam V | Device construction and method facilitating magnetic resonance imaging of foreign objects in a body |
US4858623A (en) | 1987-07-13 | 1989-08-22 | Intermedics, Inc. | Active fixation mechanism for lead assembly of an implantable cardiac stimulator |
US4766381A (en) | 1987-08-12 | 1988-08-23 | Vanderbilt University | Driven inversion spin echo magnetic resonance imaging |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US5372138A (en) | 1988-03-21 | 1994-12-13 | Boston Scientific Corporation | Acousting imaging catheters and the like |
US5178159A (en) | 1988-11-02 | 1993-01-12 | Cardiometrics, Inc. | Torqueable guide wire assembly with electrical functions, male and female connectors rotatable with respect to one another |
US4945912A (en) * | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US4940052A (en) | 1989-01-25 | 1990-07-10 | Siemens-Pacesetter, Inc. | Microprocessor controlled rate-responsive pacemaker having automatic rate response threshold adjustment |
US5063348A (en) | 1989-02-23 | 1991-11-05 | Kabushiki Kaisha Toshiba | Magnetic resonance imaging system |
US5348010A (en) | 1989-02-24 | 1994-09-20 | Medrea, Inc., Pennsylvania Corp., Pa. | Intracavity probe and interface device for MRI imaging and spectroscopy |
US5052404A (en) | 1989-03-02 | 1991-10-01 | The Microspring Company, Inc. | Torque transmitter |
US4991580A (en) | 1989-03-30 | 1991-02-12 | Invivo Research, Inc. | Method of improving the quality of an electrocardiogram obtained from a patient undergoing magnetic resonance imaging |
US4944298A (en) | 1989-05-23 | 1990-07-31 | Siemens-Pacesetter, Inc. | Atrial rate based programmable pacemaker with automatic mode switching means |
DE3926934A1 (en) | 1989-08-16 | 1991-02-21 | Deutsches Krebsforsch | HYPERTHERMIC MICROWAVE APPLICATOR FOR WARMING A LIMITED ENVIRONMENT IN A DISSIPATIVE MEDIUM |
US5099208A (en) | 1989-10-05 | 1992-03-24 | Vanderbilt University | Method for magnetic resonance imaging and related apparatus |
US5044375A (en) | 1989-12-08 | 1991-09-03 | Cardiac Pacemakers, Inc. | Unitary intravascular defibrillating catheter with separate bipolar sensing |
US5197468A (en) | 1990-02-13 | 1993-03-30 | Proctor Paul W | Device for protecting an electronic prosthesis from adverse effects of RF and/or electrostatic energy |
US5558093A (en) | 1990-05-18 | 1996-09-24 | Cardiovascular Imaging Systems, Inc. | Guidewire with imaging capability |
US5095911A (en) | 1990-05-18 | 1992-03-17 | Cardiovascular Imaging Systems, Inc. | Guidewire with imaging capability |
US5122363A (en) | 1990-12-07 | 1992-06-16 | Board Of Regents, The University Of Texas System | Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract |
US5167233A (en) | 1991-01-07 | 1992-12-01 | Endosonics Corporation | Dilating and imaging apparatus |
US5178618A (en) | 1991-01-16 | 1993-01-12 | Brigham And Womens Hospital | Method and device for recanalization of a body passageway |
US5353798A (en) | 1991-03-13 | 1994-10-11 | Scimed Life Systems, Incorporated | Intravascular imaging apparatus and methods for use and manufacture |
WO1992021285A1 (en) | 1991-05-24 | 1992-12-10 | Ep Technologies, Inc. | Combination monophasic action potential/ablation catheter and high-performance filter system |
US5217010A (en) | 1991-05-28 | 1993-06-08 | The Johns Hopkins University | Ecg amplifier and cardiac pacemaker for use during magnetic resonance imaging |
US5222506A (en) | 1991-07-29 | 1993-06-29 | Medtronic, Inc. | Implantable medical lead with electrical cross-over adaptor |
US5211165A (en) | 1991-09-03 | 1993-05-18 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency field gradients |
US5307814A (en) | 1991-09-17 | 1994-05-03 | Medrad, Inc. | Externally moveable intracavity probe for MRI imaging and spectroscopy |
NL9201724A (en) | 1991-10-07 | 1993-05-03 | Medrad Inc En The Trustees Of | PROBE FOR MRI IMAGING AND SPECTROSCOPY, ESPECIALLY IN THE CERVICAL AREA. |
US5323778A (en) | 1991-11-05 | 1994-06-28 | Brigham & Women's Hospital | Method and apparatus for magnetic resonance imaging and heating tissues |
US5445150A (en) | 1991-11-18 | 1995-08-29 | General Electric Company | Invasive system employing a radiofrequency tracking system |
US5437277A (en) | 1991-11-18 | 1995-08-01 | General Electric Company | Inductively coupled RF tracking system for use in invasive imaging of a living body |
US5498261A (en) | 1991-12-20 | 1996-03-12 | Advanced Cardiovascular Systems, Inc. | Thermal angioplasty system |
US5428337A (en) | 1992-02-21 | 1995-06-27 | Vlt Corporation | Conductive winding |
US5306291A (en) | 1992-02-26 | 1994-04-26 | Angeion Corporation | Optimal energy steering for an implantable defibrillator |
US5318025A (en) | 1992-04-01 | 1994-06-07 | General Electric Company | Tracking system to monitor the position and orientation of a device using multiplexed magnetic resonance detection |
US5271400A (en) | 1992-04-01 | 1993-12-21 | General Electric Company | Tracking system to monitor the position and orientation of a device using magnetic resonance detection of a sample contained within the device |
US5307808A (en) | 1992-04-01 | 1994-05-03 | General Electric Company | Tracking system and pulse sequences to monitor the position of a device using magnetic resonance |
US5578008A (en) | 1992-04-22 | 1996-11-26 | Japan Crescent, Inc. | Heated balloon catheter |
US5190046A (en) | 1992-05-01 | 1993-03-02 | Shturman Cardiology Systems, Inc. | Ultrasound imaging balloon catheter |
US5352979A (en) | 1992-08-07 | 1994-10-04 | Conturo Thomas E | Magnetic resonance imaging with contrast enhanced phase angle reconstruction |
IL106779A0 (en) | 1992-09-11 | 1993-12-08 | Magna Lab Inc | Permanent magnetic structure |
US5662108A (en) | 1992-09-23 | 1997-09-02 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5323776A (en) | 1992-10-15 | 1994-06-28 | Picker International, Inc. | MRI compatible pulse oximetry system |
NL9201965A (en) | 1992-11-10 | 1994-06-01 | Draeger Med Electronics Bv | Invasive MRI transducer. |
US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US5334045A (en) * | 1992-11-20 | 1994-08-02 | Siemens Pacesetter, Inc. | Universal cable connector for temporarily connecting implantable leads and implantable medical devices with a non-implantable system analyzer |
US5365928A (en) | 1992-11-25 | 1994-11-22 | Medrad, Inc. | Endorectal probe with planar moveable MRI coil |
US5300108A (en) | 1993-01-05 | 1994-04-05 | Telectronics Pacing Systems, Inc. | Active fixation lead with a dual-pitch, free spinning compound screw |
US5433717A (en) | 1993-03-23 | 1995-07-18 | The Regents Of The University Of California | Magnetic resonance imaging assisted cryosurgery |
EP0750520B1 (en) | 1993-04-14 | 2000-08-09 | Pharmacyclics, Inc. | Medical devices and materials having enhanced magnetic images visibility |
US5333095A (en) | 1993-05-03 | 1994-07-26 | Maxwell Laboratories, Inc., Sierra Capacitor Filter Division | Feedthrough filter capacitor assembly for human implant |
WO1995001751A1 (en) | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5840031A (en) | 1993-07-01 | 1998-11-24 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials and ablating tissue |
US5391199A (en) | 1993-07-20 | 1995-02-21 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias |
FR2708860B1 (en) | 1993-08-11 | 1995-10-13 | Ela Medical Sa | Protection circuit for implantable electronic device. |
US5363845A (en) | 1993-08-13 | 1994-11-15 | Medical Advances, Inc. | Breast coil for magnetic resonance imaging |
US5466254A (en) | 1993-09-22 | 1995-11-14 | Pacesetter, Inc. | Coronary sinus lead with atrial sensing capability |
US5404880A (en) | 1993-10-05 | 1995-04-11 | Board Of Regents Of University Of Nebraska | Scatter diagram analysis system and method for discriminating ventricular tachyarrhythmias |
US5558091A (en) | 1993-10-06 | 1996-09-24 | Biosense, Inc. | Magnetic determination of position and orientation |
US5507743A (en) | 1993-11-08 | 1996-04-16 | Zomed International | Coiled RF electrode treatment apparatus |
US5400787A (en) | 1993-11-24 | 1995-03-28 | Magna-Lab, Inc. | Inflatable magnetic resonance imaging sensing coil assembly positioning and retaining device and method for using the same |
US6099524A (en) | 1994-01-28 | 2000-08-08 | Cardiac Pacemakers, Inc. | Electrophysiological mapping and ablation catheter and method |
EP0673621B1 (en) | 1994-03-18 | 1998-03-04 | Schneider (Europe) Ag | A magnetic resonance imaging system for tracking a medical appliance |
US5447156A (en) | 1994-04-04 | 1995-09-05 | General Electric Company | Magnetic resonance (MR) active invasive devices for the generation of selective MR angiograms |
US5824029A (en) | 1994-04-28 | 1998-10-20 | Medtronic, Inc. | Implantable medical system for performing transthoracic impedance measurements associated with cardiac function |
US5476483A (en) | 1994-06-10 | 1995-12-19 | Pacesetter, Inc. | System and method for modulating the base rate during sleep for a rate-responsive cardiac pacemaker |
US5782891A (en) | 1994-06-16 | 1998-07-21 | Medtronic, Inc. | Implantable ceramic enclosure for pacing, neurological, and other medical applications in the human body |
US5419325A (en) | 1994-06-23 | 1995-05-30 | General Electric Company | Magnetic resonance (MR) angiography using a faraday catheter |
US5462055A (en) | 1994-08-23 | 1995-10-31 | Northrop Grumman Corporation | MRI/hyperthermia dual function antenna system |
US5735884A (en) | 1994-10-04 | 1998-04-07 | Medtronic, Inc. | Filtered feedthrough assembly for implantable medical device |
US5512825A (en) | 1994-11-25 | 1996-04-30 | The Johns Hopkins University | Method of minimizing dead-periods in magnetic resonance imaging pulse sequences and associated apparatus |
US6690963B2 (en) | 1995-01-24 | 2004-02-10 | Biosense, Inc. | System for determining the location and orientation of an invasive medical instrument |
US5630426A (en) | 1995-03-03 | 1997-05-20 | Neovision Corporation | Apparatus and method for characterization and treatment of tumors |
US5769800A (en) | 1995-03-15 | 1998-06-23 | The Johns Hopkins University Inc. | Vest design for a cardiopulmonary resuscitation system |
US5545201A (en) | 1995-03-29 | 1996-08-13 | Pacesetter, Inc. | Bipolar active fixation lead for sensing and pacing the heart |
US5699801A (en) | 1995-06-01 | 1997-12-23 | The Johns Hopkins University | Method of internal magnetic resonance imaging and spectroscopic analysis and associated apparatus |
US5722998A (en) | 1995-06-07 | 1998-03-03 | Intermedics, Inc. | Apparatus and method for the control of an implantable medical device |
US5697958A (en) | 1995-06-07 | 1997-12-16 | Intermedics, Inc. | Electromagnetic noise detector for implantable medical devices |
US5629622A (en) | 1995-07-11 | 1997-05-13 | Hewlett-Packard Company | Magnetic field sense system for the protection of connected electronic devices |
US5590657A (en) | 1995-11-06 | 1997-01-07 | The Regents Of The University Of Michigan | Phased array ultrasound system and method for cardiac ablation |
US5685878A (en) | 1995-11-13 | 1997-11-11 | C.R. Bard, Inc. | Snap fit distal assembly for an ablation catheter |
US5620476A (en) | 1995-11-13 | 1997-04-15 | Pacesetter, Inc. | Implantable medical device having shielded and filtered feedthrough assembly and methods for making such assembly |
DE69634035T2 (en) | 1995-11-24 | 2005-12-08 | Koninklijke Philips Electronics N.V. | SYSTEM FOR IMAGING BY MAGNETIC RESONANCE AND CATHETER FOR PROCEDURE PROCEDURE |
US5751539A (en) | 1996-04-30 | 1998-05-12 | Maxwell Laboratories, Inc. | EMI filter for human implantable heart defibrillators and pacemakers |
US5978204A (en) | 1995-11-27 | 1999-11-02 | Maxwell Energy Products, Inc. | Capacitor with dual element electrode plates |
US5800467A (en) | 1995-12-15 | 1998-09-01 | Pacesetter, Inc. | Cardio-synchronous impedance measurement system for an implantable stimulation device |
US5741321A (en) | 1996-01-11 | 1998-04-21 | Medtronic, Inc. | Active fixation medical electrical lead having improved turning tool |
US5772693A (en) * | 1996-02-09 | 1998-06-30 | Cardiac Control Systems, Inc. | Single preformed catheter configuration for a dual-chamber pacemaker system |
EP0910300B1 (en) | 1996-02-15 | 2003-12-03 | Biosense, Inc. | Site marking probe |
US5938692A (en) | 1996-03-26 | 1999-08-17 | Urologix, Inc. | Voltage controlled variable tuning antenna |
EP0803738B1 (en) | 1996-04-24 | 2003-04-02 | Philips Corporate Intellectual Property GmbH | Method of synthesizing an image for producing a combination image from input images |
US6628980B2 (en) | 2000-03-24 | 2003-09-30 | Surgi-Vision, Inc. | Apparatus, systems, and methods for in vivo magnetic resonance imaging |
US6263229B1 (en) | 1998-11-13 | 2001-07-17 | Johns Hopkins University School Of Medicine | Miniature magnetic resonance catheter coils and related methods |
US5928145A (en) | 1996-04-25 | 1999-07-27 | The Johns Hopkins University | Method of magnetic resonance imaging and spectroscopic analysis and associated apparatus employing a loopless antenna |
US7236816B2 (en) | 1996-04-25 | 2007-06-26 | Johns Hopkins University | Biopsy and sampling needle antennas for magnetic resonance imaging-guided biopsies |
US6675033B1 (en) | 1999-04-15 | 2004-01-06 | Johns Hopkins University School Of Medicine | Magnetic resonance imaging guidewire probe |
US6549800B1 (en) | 1996-04-25 | 2003-04-15 | Johns Hopkins Unversity School Of Medicine | Methods for in vivo magnetic resonance imaging |
US6898454B2 (en) | 1996-04-25 | 2005-05-24 | The Johns Hopkins University | Systems and methods for evaluating the urethra and the periurethral tissues |
US5824026A (en) | 1996-06-12 | 1998-10-20 | The Spectranetics Corporation | Catheter for delivery of electric energy and a process for manufacturing same |
US5716390A (en) | 1996-08-09 | 1998-02-10 | Pacesetter, Inc. | Reduced diameter active fixation pacing lead using concentric interleaved coils |
JP4053091B2 (en) | 1996-09-02 | 2008-02-27 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Invasive device used in magnetic resonance imaging apparatus |
US5891134A (en) | 1996-09-24 | 1999-04-06 | Goble; Colin | System and method for applying thermal energy to tissue |
US5851226A (en) | 1996-10-22 | 1998-12-22 | Medtronic, Inc. | Temporary transvenous endocardial lead |
US5779669A (en) | 1996-10-28 | 1998-07-14 | C. R. Bard, Inc. | Steerable catheter with fixed curve |
EP0846959B1 (en) | 1996-12-05 | 2006-10-18 | Philips Medical Systems (Cleveland), Inc. | Nuclear magnetic resonance radio frequency coils |
US5735887A (en) * | 1996-12-10 | 1998-04-07 | Exonix Corporation | Closed-loop, RF-coupled implanted medical device |
US5775338A (en) | 1997-01-10 | 1998-07-07 | Scimed Life Systems, Inc. | Heated perfusion balloon for reduction of restenosis |
US5879347A (en) | 1997-04-25 | 1999-03-09 | Gynecare, Inc. | Apparatus for controlled thermal treatment of tissue |
US5759202A (en) | 1997-04-28 | 1998-06-02 | Sulzer Intermedics Inc. | Endocardial lead with lateral active fixation |
US6198972B1 (en) | 1997-04-30 | 2001-03-06 | Medtronic, Inc. | Control of externally induced current in implantable medical devices |
US6026316A (en) | 1997-05-15 | 2000-02-15 | Regents Of The University Of Minnesota | Method and apparatus for use with MR imaging |
US6272370B1 (en) | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
WO1998052461A1 (en) | 1997-05-21 | 1998-11-26 | Cardiac M.R.I., Inc. | Cardiac mri with an internal receiving coil and an external receiving coil |
ATE419789T1 (en) | 1997-05-23 | 2009-01-15 | Prorhythm Inc | HIGH INTENSITY DISPOSABLE FOCUSING ULTRASONIC APPLICATOR |
WO1998056294A1 (en) | 1997-06-12 | 1998-12-17 | The Johns Hopkins University School Of Medicine | Method for measuring myocardial motion and the like |
EP0884024B1 (en) | 1997-06-13 | 2003-08-13 | Sulzer Osypka GmbH | Multipolar ablation catheter |
US5964705A (en) | 1997-08-22 | 1999-10-12 | Image-Guided Drug Delivery System, Inc. | MR-compatible medical devices |
US5905627A (en) | 1997-09-10 | 1999-05-18 | Maxwell Energy Products, Inc. | Internally grounded feedthrough filter capacitor |
US6052614A (en) | 1997-09-12 | 2000-04-18 | Magnetic Resonance Equipment Corp. | Electrocardiograph sensor and sensor control system for use with magnetic resonance imaging machines |
GB2330202A (en) | 1997-10-07 | 1999-04-14 | Marconi Gec Ltd | Flexible MRI antenna for intra-cavity use |
DE19746735C2 (en) | 1997-10-13 | 2003-11-06 | Simag Gmbh Systeme Und Instr F | NMR imaging method for the display, position determination or functional control of a device inserted into an examination object and device for use in such a method |
US6643903B2 (en) | 1997-11-13 | 2003-11-11 | Greatbatch-Sierra, Inc. | Process for manufacturing an EMI filter feedthrough terminal assembly |
US6275369B1 (en) | 1997-11-13 | 2001-08-14 | Robert A. Stevenson | EMI filter feedthough terminal assembly having a capture flange to facilitate automated assembly |
US6008980A (en) | 1997-11-13 | 1999-12-28 | Maxwell Energy Products, Inc. | Hermetically sealed EMI feedthrough filter capacitor for human implant and other applications |
US6129670A (en) | 1997-11-24 | 2000-10-10 | Burdette Medical Systems | Real time brachytherapy spatial registration and visualization system |
US6031375A (en) | 1997-11-26 | 2000-02-29 | The Johns Hopkins University | Method of magnetic resonance analysis employing cylindrical coordinates and an associated apparatus |
KR100279753B1 (en) | 1997-12-03 | 2001-03-02 | 정선종 | Inductor manufacturing method using semiconductor integrated circuit manufacturing process |
DE19755782A1 (en) | 1997-12-16 | 1999-06-17 | Philips Patentverwaltung | Magnetic resonance device |
US6141594A (en) | 1998-07-22 | 2000-10-31 | Cardiac Pacemakers, Inc. | Single pass lead and system with active and passive fixation elements |
US6011995A (en) | 1997-12-29 | 2000-01-04 | The Regents Of The University Of California | Endovascular device for hyperthermia and angioplasty and method for using the same |
US5959829A (en) | 1998-02-18 | 1999-09-28 | Maxwell Energy Products, Inc. | Chip capacitor electromagnetic interference filter |
US6045532A (en) | 1998-02-20 | 2000-04-04 | Arthrocare Corporation | Systems and methods for electrosurgical treatment of tissue in the brain and spinal cord |
US6055457A (en) | 1998-03-13 | 2000-04-25 | Medtronic, Inc. | Single pass A-V lead with active fixation device |
US5973906A (en) | 1998-03-17 | 1999-10-26 | Maxwell Energy Products, Inc. | Chip capacitors and chip capacitor electromagnetic interference filters |
US6759388B1 (en) | 1999-04-29 | 2004-07-06 | Nanomimetics, Inc. | Surfactants that mimic the glycocalyx |
US6027500A (en) * | 1998-05-05 | 2000-02-22 | Buckles; David S. | Cardiac ablation system |
US6101417A (en) | 1998-05-12 | 2000-08-08 | Pacesetter, Inc. | Implantable electrical device incorporating a magnetoresistive magnetic field sensor |
US6428537B1 (en) | 1998-05-22 | 2002-08-06 | Scimed Life Systems, Inc. | Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive |
US6238390B1 (en) | 1998-05-27 | 2001-05-29 | Irvine Biomedical, Inc. | Ablation catheter system having linear lesion capabilities |
US6370427B1 (en) | 1998-07-23 | 2002-04-09 | Intermedics, Inc. | Method and apparatus for dual chamber bi-ventricular pacing and defibrillation |
AU4644799A (en) | 1998-08-02 | 2000-03-14 | Super Dimension Ltd. | Intrabody navigation system for medical applications |
SE9802928D0 (en) | 1998-08-31 | 1998-08-31 | Pacesetter Ab | Device in connection with pacers I |
US6424234B1 (en) | 1998-09-18 | 2002-07-23 | Greatbatch-Sierra, Inc. | Electromagnetic interference (emi) filter and process for providing electromagnetic compatibility of an electronic device while in the presence of an electromagnetic emitter operating at the same frequency |
US6408202B1 (en) | 1998-11-03 | 2002-06-18 | The Johns Hopkins University | Transesophageal magnetic resonance analysis method and apparatus |
US6701176B1 (en) | 1998-11-04 | 2004-03-02 | Johns Hopkins University School Of Medicine | Magnetic-resonance-guided imaging, electrophysiology, and ablation |
US7844319B2 (en) | 1998-11-04 | 2010-11-30 | Susil Robert C | Systems and methods for magnetic-resonance-guided interventional procedures |
US9061139B2 (en) | 1998-11-04 | 2015-06-23 | Greatbatch Ltd. | Implantable lead with a band stop filter having a capacitor in parallel with an inductor embedded in a dielectric body |
US8244370B2 (en) | 2001-04-13 | 2012-08-14 | Greatbatch Ltd. | Band stop filter employing a capacitor and an inductor tank circuit to enhance MRI compatibility of active medical devices |
US6390996B1 (en) | 1998-11-09 | 2002-05-21 | The Johns Hopkins University | CPR chest compression monitor |
US6284971B1 (en) | 1998-11-25 | 2001-09-04 | Johns Hopkins University School Of Medicine | Enhanced safety coaxial cables |
US6159560A (en) | 1998-11-25 | 2000-12-12 | Stevenson; Robert A. | Process for depositing a metal coating on a metallic component of an electrical structure |
US6188219B1 (en) | 1999-01-22 | 2001-02-13 | The Johns Hopkins University | Magnetic resonance imaging method and apparatus and method of calibrating the same |
SE9900682D0 (en) | 1999-02-25 | 1999-02-25 | Pacesetter Ab | Implantable tissue stimulating device |
AU1198700A (en) | 1999-03-16 | 2000-10-04 | Maxwell Energy Products | Low inductance four terminal capacitor lead frame |
SE9901032D0 (en) | 1999-03-22 | 1999-03-22 | Pacesetter Ab | Medical electrode lead |
US7848788B2 (en) | 1999-04-15 | 2010-12-07 | The Johns Hopkins University | Magnetic resonance imaging probe |
WO2000074769A2 (en) | 1999-06-07 | 2000-12-14 | Johns Hopkins University | Cardiac shock electrode system and corresponding implantable defibrillator system |
US20040015079A1 (en) | 1999-06-22 | 2004-01-22 | Teratech Corporation | Ultrasound probe with integrated electronics |
US7149773B2 (en) * | 1999-07-07 | 2006-12-12 | Medtronic, Inc. | System and method of automated invoicing for communications between an implantable medical device and a remote computer system or health care provider |
JP3480384B2 (en) | 1999-09-10 | 2003-12-15 | 株式会社村田製作所 | Laminated LC resonator and laminated LC filter |
US6227515B1 (en) | 1999-10-27 | 2001-05-08 | Michelle Broyles | Variable mass platform |
WO2001056469A2 (en) | 2000-02-01 | 2001-08-09 | Surgi-Vision, Inc. | Magnetic resonance imaging transseptal needle antenna |
SE0000548D0 (en) | 2000-02-18 | 2000-02-18 | Pacesetter Ab | Electrode |
US6414835B1 (en) | 2000-03-01 | 2002-07-02 | Medtronic, Inc. | Capacitive filtered feedthrough array for an implantable medical device |
FR2805998B1 (en) * | 2000-03-07 | 2002-10-18 | Ela Medical Sa | ACTIVE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR A CARDIAC STIMULATOR, A DEFIBRILLATOR AND / OR A MULTI-SITE CARDIOVERVER PROVIDED WITH MEANS OF MEASUREMENT OF INTRACARDIAC IMPEDANCE |
SE0001112D0 (en) | 2000-03-29 | 2000-03-29 | Pacesetter Ab | Implantable heart stimulator |
US6925328B2 (en) | 2000-04-20 | 2005-08-02 | Biophan Technologies, Inc. | MRI-compatible implantable device |
AU2001255522A1 (en) | 2000-04-20 | 2001-11-07 | Greatbio Technologies, Inc. | Mri-resistant implantable device |
US20020095197A1 (en) | 2000-07-11 | 2002-07-18 | Lardo Albert C. | Application of photochemotherapy for the treatment of cardiac arrhythmias |
US6459935B1 (en) | 2000-07-13 | 2002-10-01 | Avx Corporation | Integrated filter feed-thru |
US20020055678A1 (en) | 2000-07-13 | 2002-05-09 | Scott Greig C. | Electrode probe coil for MRI |
US6493591B1 (en) | 2000-07-19 | 2002-12-10 | Medtronic, Inc. | Implantable active fixation lead with guidewire tip |
US6535766B1 (en) | 2000-08-26 | 2003-03-18 | Medtronic, Inc. | Implanted medical device telemetry using integrated microelectromechanical filtering |
US6539253B2 (en) | 2000-08-26 | 2003-03-25 | Medtronic, Inc. | Implantable medical device incorporating integrated circuit notch filters |
US6868288B2 (en) | 2000-08-26 | 2005-03-15 | Medtronic, Inc. | Implanted medical device telemetry using integrated thin film bulk acoustic resonator filtering |
US6529103B1 (en) | 2000-09-07 | 2003-03-04 | Greatbatch-Sierra, Inc. | Internally grounded feedthrough filter capacitor with improved ground plane design for human implant and other applications |
US6882248B2 (en) | 2000-09-07 | 2005-04-19 | Greatbatch-Sierra, Inc. | EMI filtered connectors using internally grounded feedthrough capacitors |
SE0003341D0 (en) | 2000-09-18 | 2000-09-18 | St Jude Medical | A coating method |
US6654628B1 (en) | 2000-11-03 | 2003-11-25 | The Johns Hopkins University | Methods to assess vascular endothelial function |
US6567703B1 (en) | 2000-11-08 | 2003-05-20 | Medtronic, Inc. | Implantable medical device incorporating miniaturized circuit module |
SE0004240D0 (en) | 2000-11-17 | 2000-11-17 | St Jude Medical | A cardiac stimulating device |
CA2468252A1 (en) | 2000-11-20 | 2002-05-23 | Surgi-Vision, Inc. | Connector and guidewire connectable thereto |
US6556009B2 (en) | 2000-12-11 | 2003-04-29 | The United States Of America As Represented By The Department Of Health And Human Services | Accelerated magnetic resonance imaging using a parallel spatial filter |
US6876885B2 (en) | 2001-01-31 | 2005-04-05 | Medtronic, Inc. | Implantable bifurcated gastrointestinal lead with active fixation |
US6952613B2 (en) | 2001-01-31 | 2005-10-04 | Medtronic, Inc. | Implantable gastrointestinal lead with active fixation |
US8068893B2 (en) | 2001-02-16 | 2011-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Real-time, interactive volumetric magnetic resonance imaging |
US20070168005A1 (en) | 2001-02-20 | 2007-07-19 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US6949929B2 (en) | 2003-06-24 | 2005-09-27 | Biophan Technologies, Inc. | Magnetic resonance imaging interference immune device |
US6829509B1 (en) | 2001-02-20 | 2004-12-07 | Biophan Technologies, Inc. | Electromagnetic interference immune tissue invasive system |
US20070168006A1 (en) | 2001-02-20 | 2007-07-19 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US6362012B1 (en) | 2001-03-05 | 2002-03-26 | Taiwan Semiconductor Manufacturing Company | Structure of merged vertical capacitor inside spiral conductor for RF and mixed-signal applications |
US6901292B2 (en) | 2001-03-19 | 2005-05-31 | Medtronic, Inc. | Control of externally induced current in an implantable pulse generator |
US6771067B2 (en) | 2001-04-03 | 2004-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Ghost artifact cancellation using phased array processing |
US20020192688A1 (en) | 2001-04-05 | 2002-12-19 | Xiaoming Yang | Imaging nucleic acid delivery |
WO2002083016A1 (en) | 2001-04-13 | 2002-10-24 | Surgi-Vision, Inc. | Systems and methods for magnetic-resonance-guided interventional procedures |
US8195295B2 (en) | 2008-03-20 | 2012-06-05 | Greatbatch Ltd. | Shielded three-terminal flat-through EMI/energy dissipating filter |
US8000801B2 (en) | 2001-04-13 | 2011-08-16 | Greatbatch Ltd. | System for terminating abandoned implanted leads to minimize heating in high power electromagnetic field environments |
US20070088416A1 (en) | 2001-04-13 | 2007-04-19 | Surgi-Vision, Inc. | Mri compatible medical leads |
US8600519B2 (en) | 2001-04-13 | 2013-12-03 | Greatbatch Ltd. | Transient voltage/current protection system for electronic circuits associated with implanted leads |
US7899551B2 (en) | 2001-04-13 | 2011-03-01 | Greatbatch Ltd. | Medical lead system utilizing electromagnetic bandstop filters |
US20090163980A1 (en) | 2007-12-21 | 2009-06-25 | Greatbatch Ltd. | Switch for turning off therapy delivery of an active implantable medical device during mri scans |
US7853325B2 (en) | 2001-04-13 | 2010-12-14 | Greatbatch Ltd. | Cylindrical bandstop filters for medical lead systems |
US20030208252A1 (en) | 2001-05-14 | 2003-11-06 | O' Boyle Gary S. | Mri ablation catheter |
US6456481B1 (en) | 2001-05-31 | 2002-09-24 | Greatbatch-Sierra, Inc. | Integrated EMI filter-DC blocking capacitor |
US6567259B2 (en) | 2001-05-31 | 2003-05-20 | Greatbatch-Sierra, Inc. | Monolithic ceramic capacitor with barium titinate dielectric curie point optimized for active implantable medical devices operating at 37° C. |
US6687550B1 (en) | 2001-06-01 | 2004-02-03 | Pacesetter, Inc. | Active fixation electrode lead having an electrical coupling mechanism |
US6697675B1 (en) | 2001-06-14 | 2004-02-24 | Pacesetter, Inc. | Laser welded joint for implantable lead |
US6892086B2 (en) | 2001-07-11 | 2005-05-10 | Michael J. Russell | Medical electrode for preventing the passage of harmful current to a patient |
US6675036B2 (en) | 2001-07-18 | 2004-01-06 | Ge Medical Systems, Inc. | Diagnostic device including a method and apparatus for bio-potential noise cancellation utilizing the patient's respiratory signal |
US7039455B1 (en) | 2001-10-09 | 2006-05-02 | Medrad, Inc. | Apparatus and method for removing magnetic resonance imaging-induced noise from ECG signals |
US7076283B2 (en) | 2001-10-31 | 2006-07-11 | Medtronic, Inc. | Device for sensing cardiac activity in an implantable medical device in the presence of magnetic resonance imaging interference |
US6871091B2 (en) | 2001-10-31 | 2005-03-22 | Medtronic, Inc. | Apparatus and method for shunting induced currents in an electrical lead |
US6944489B2 (en) | 2001-10-31 | 2005-09-13 | Medtronic, Inc. | Method and apparatus for shunting induced currents in an electrical lead |
US6950696B2 (en) | 2001-11-27 | 2005-09-27 | St. Jude Medical Ab | Method and circuit for detecting cardiac rhythm abnormalities by analyzing time differences between unipolar signals from a lead with a multi-electrode tip |
US6728575B2 (en) | 2001-11-30 | 2004-04-27 | St. Jude Medical Ab | Method and circuit for detecting cardiac rhythm abnormalities using a differential signal from a lead with a multi-electrode tip |
US6506972B1 (en) | 2002-01-22 | 2003-01-14 | Nanoset, Llc | Magnetically shielded conductor |
US6864418B2 (en) | 2002-12-18 | 2005-03-08 | Nanoset, Llc | Nanomagnetically shielded substrate |
US20040210289A1 (en) | 2002-03-04 | 2004-10-21 | Xingwu Wang | Novel nanomagnetic particles |
US7162302B2 (en) | 2002-03-04 | 2007-01-09 | Nanoset Llc | Magnetically shielded assembly |
US20050247472A1 (en) | 2002-01-22 | 2005-11-10 | Helfer Jeffrey L | Magnetically shielded conductor |
US7091412B2 (en) | 2002-03-04 | 2006-08-15 | Nanoset, Llc | Magnetically shielded assembly |
US20030144719A1 (en) | 2002-01-29 | 2003-07-31 | Zeijlemaker Volkert A. | Method and apparatus for shielding wire for MRI resistant electrode systems |
US20030144718A1 (en) | 2002-01-29 | 2003-07-31 | Zeijlemaker Volkert A. | Method and apparatus for shielding coating for MRI resistant electrode systems |
US7050855B2 (en) | 2002-01-29 | 2006-05-23 | Medtronic, Inc. | Medical implantable system for reducing magnetic resonance effects |
US6937906B2 (en) | 2002-01-29 | 2005-08-30 | Medtronic, Inc. | Method and apparatus for detecting static magnetic fields |
US7082328B2 (en) | 2002-01-29 | 2006-07-25 | Medtronic, Inc. | Methods and apparatus for controlling a pacing system in the presence of EMI |
US20030144720A1 (en) | 2002-01-29 | 2003-07-31 | Villaseca Eduardo H. | Electromagnetic trap for a lead |
US6985775B2 (en) | 2002-01-29 | 2006-01-10 | Medtronic, Inc. | Method and apparatus for shunting induced currents in an electrical lead |
WO2003063954A1 (en) | 2002-01-29 | 2003-08-07 | Medtronic, Inc. | Conditioning of coupled electromagnetic signals on a lead |
US20030144706A1 (en) | 2002-01-29 | 2003-07-31 | Funke Hermann D. | Method and apparatus for controlling an implantable medical device in response to the presence of a magnetic field and/or high frequency radiation interference signals |
US6985347B2 (en) | 2002-02-28 | 2006-01-10 | Greatbatch-Sierra, Inc. | EMI filter capacitors designed for direct body fluid exposure |
AU2003213646A1 (en) | 2002-02-28 | 2003-09-09 | Greatbatch-Sierra, Inc. | Emi feedthrough filter terminal assembly for human implant applications utilizing oxide resistant biostable conductive pads for reliable electrical attachments |
US7127294B1 (en) | 2002-12-18 | 2006-10-24 | Nanoset Llc | Magnetically shielded assembly |
US20090259279A1 (en) | 2002-03-22 | 2009-10-15 | Dobak Iii John D | Splanchnic nerve stimulation for treatment of obesity |
US7422568B2 (en) | 2002-04-01 | 2008-09-09 | The Johns Hopkins University | Device, systems and methods for localized heating of a vessel and/or in combination with MR/NMR imaging of the vessel and surrounding tissue |
US8396568B2 (en) | 2002-04-11 | 2013-03-12 | Medtronic, Inc. | Medical electrical lead body designs incorporating energy dissipating shunt |
US20030204217A1 (en) | 2002-04-25 | 2003-10-30 | Wilson Greatbatch | MRI-safe cardiac stimulation device |
JP4071536B2 (en) | 2002-05-07 | 2008-04-02 | 富士通株式会社 | Test apparatus for file apparatus and test method in test apparatus for file apparatus |
US6939327B2 (en) | 2002-05-07 | 2005-09-06 | Cardiac Pacemakers, Inc. | Peel-away sheath |
US6904307B2 (en) | 2002-05-29 | 2005-06-07 | Surgi-Vision, Inc. | Magnetic resonance probes |
US6675779B2 (en) | 2002-06-13 | 2004-01-13 | Stant Manufacturing Inc. | Dual float valve for fuel tank vent with liquid carryover filter |
US20040034338A1 (en) | 2002-08-07 | 2004-02-19 | Ams Research Corporation | Drug delivery devices and methods |
US6675780B1 (en) | 2002-09-24 | 2004-01-13 | Antonius G. Wendels | Fuel saving and pollution emission reduction system for internal combustion engines |
US7103418B2 (en) | 2002-10-02 | 2006-09-05 | Medtronic, Inc. | Active fluid delivery catheter |
US7164950B2 (en) | 2002-10-30 | 2007-01-16 | Pacesetter, Inc. | Implantable stimulation device with isolating system for minimizing magnetic induction |
US7038900B2 (en) | 2003-02-27 | 2006-05-02 | Greatbatch-Sierra, Inc. | EMI filter terminal assembly with wire bond pads for human implant applications |
US6999818B2 (en) | 2003-05-23 | 2006-02-14 | Greatbatch-Sierra, Inc. | Inductor capacitor EMI filter for human implant applications |
US7623335B2 (en) | 2003-02-27 | 2009-11-24 | Greatbatch-Sierra, Inc | Hermetic feedthrough terminal assembly with wire bond pads for human implant applications |
US20040199069A1 (en) | 2003-04-02 | 2004-10-07 | Connelly Patrick R. | Device and method for preventing magnetic resonance imaging induced damage |
US7388378B2 (en) | 2003-06-24 | 2008-06-17 | Medtronic, Inc. | Magnetic resonance imaging interference immune device |
US7839146B2 (en) | 2003-06-24 | 2010-11-23 | Medtronic, Inc. | Magnetic resonance imaging interference immune device |
SE0301980D0 (en) | 2003-07-03 | 2003-07-03 | St Jude Medical | Implantable medical device |
US20050070972A1 (en) | 2003-09-26 | 2005-03-31 | Wahlstrand Carl D. | Energy shunt for producing an MRI-safe implantable medical device |
US7092766B1 (en) | 2003-11-19 | 2006-08-15 | Pacesetter, Inc. | Active fixation lead with multiple density |
US7765005B2 (en) | 2004-02-12 | 2010-07-27 | Greatbatch Ltd. | Apparatus and process for reducing the susceptability of active implantable medical devices to medical procedures such as magnetic resonance imaging |
US8057401B2 (en) | 2005-02-24 | 2011-11-15 | Erich Wolf | System for transcutaneous monitoring of intracranial pressure |
US7505814B2 (en) | 2004-03-26 | 2009-03-17 | Pacesetter, Inc. | System and method for evaluating heart failure based on ventricular end-diastolic volume using an implantable medical device |
US7174219B2 (en) | 2004-03-30 | 2007-02-06 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US8989840B2 (en) | 2004-03-30 | 2015-03-24 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7844344B2 (en) | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable lead |
US9155877B2 (en) | 2004-03-30 | 2015-10-13 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7844343B2 (en) | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable medical device |
WO2005102447A1 (en) | 2004-03-30 | 2005-11-03 | Medtronic, Inc. | Mri-safe implantable lead |
US7877150B2 (en) | 2004-03-30 | 2011-01-25 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7489495B2 (en) | 2004-04-15 | 2009-02-10 | Greatbatch-Sierra, Inc. | Apparatus and process for reducing the susceptibility of active implantable medical devices to medical procedures such as magnetic resonance imaging |
US7035076B1 (en) | 2005-08-15 | 2006-04-25 | Greatbatch-Sierra, Inc. | Feedthrough filter capacitor assembly with internally grounded hermetic insulator |
US7253615B2 (en) | 2004-05-05 | 2007-08-07 | General Electric Company | Microelectromechanical system sensor and method for using |
US7912552B2 (en) * | 2004-07-12 | 2011-03-22 | Medtronic, Inc. | Medical electrical device including novel means for reducing high frequency electromagnetic field-induced tissue heating |
US8874228B2 (en) | 2004-07-27 | 2014-10-28 | The Cleveland Clinic Foundation | Integrated system and method for MRI-safe implantable devices |
US8509876B2 (en) | 2004-08-09 | 2013-08-13 | The Johns Hopkins University | Implantable MRI compatible stimulation leads and antennas and related systems and methods |
US8041433B2 (en) | 2004-08-20 | 2011-10-18 | Medtronic, Inc. | Magnetic resonance imaging interference immune device |
US7771411B2 (en) | 2004-09-24 | 2010-08-10 | Syntheon, Llc | Methods for operating a selective stiffening catheter |
US7148783B2 (en) | 2004-11-05 | 2006-12-12 | Harris Corporation | Microwave tunable inductor and associated methods |
US7433739B1 (en) * | 2004-11-30 | 2008-10-07 | Pacesetter, Inc. | Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access |
US7369898B1 (en) | 2004-12-22 | 2008-05-06 | Pacesetter, Inc. | System and method for responding to pulsed gradient magnetic fields using an implantable medical device |
US8280526B2 (en) | 2005-02-01 | 2012-10-02 | Medtronic, Inc. | Extensible implantable medical lead |
US8160705B2 (en) | 2005-02-23 | 2012-04-17 | Greatbatch Ltd | Shielded RF distance telemetry pin wiring for active implantable medical devices |
US8825180B2 (en) | 2005-03-31 | 2014-09-02 | Medtronic, Inc. | Medical electrical lead with co-radial multi-conductor coil |
US8027736B2 (en) | 2005-04-29 | 2011-09-27 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7853332B2 (en) | 2005-04-29 | 2010-12-14 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
CA2606824C (en) | 2005-05-04 | 2015-11-24 | Surgi-Vision, Inc. | Improved electrical lead for an electronic device such as an implantable device |
US7555350B2 (en) | 2005-05-27 | 2009-06-30 | Medtronic, Inc. | Electromagnetic interference immune pacing/defibrillation lead |
US7529590B2 (en) | 2005-05-27 | 2009-05-05 | Medtronic, Inc. | Electromagnetic interference immune pacing/defibrillation lead |
US20070083244A1 (en) | 2005-10-06 | 2007-04-12 | Greatbatch-Sierra, Inc. | Process for tuning an emi filter to reduce the amount of heat generated in implanted lead wires during medical procedures such as magnetic resonance imaging |
AU2006304775B2 (en) | 2005-10-21 | 2011-11-17 | Boston Scientific Neuromodulation Corporation | MRI-safe high impedance lead systems and related methods |
US8233985B2 (en) | 2005-11-04 | 2012-07-31 | Kenergy, Inc. | MRI compatible implanted electronic medical device with power and data communication capability |
US7917213B2 (en) | 2005-11-04 | 2011-03-29 | Kenergy, Inc. | MRI compatible implanted electronic medical lead |
US8255054B2 (en) | 2005-11-04 | 2012-08-28 | Kenergy, Inc. | MRI compatible implanted electronic medical device |
JP2009514617A (en) | 2005-11-11 | 2009-04-09 | グレートバッチ リミテッド | Tank filter placed in series with active medical device lead wires or circuitry to enhance MRI compatibility |
WO2007117302A2 (en) | 2005-11-11 | 2007-10-18 | Greatbatch Ltd. | Low loss band pass filter for rf distance telemetry pin antennas of active implantable medical devices |
US7853324B2 (en) | 2005-11-11 | 2010-12-14 | Greatbatch Ltd. | Tank filters utilizing very low K materials, in series with lead wires or circuits of active medical devices to enhance MRI compatibility |
US9901731B2 (en) | 2006-01-31 | 2018-02-27 | Medtronic, Inc. | Medical electrical lead having improved inductance |
US9037257B2 (en) | 2006-04-07 | 2015-05-19 | Medtronic, Inc. | Resonance tuning module for implantable devices and leads |
US20070250143A1 (en) | 2006-04-19 | 2007-10-25 | Sommer John L | Multi-conductor ribbon coiled medical device lead |
US7933662B2 (en) | 2006-04-26 | 2011-04-26 | Marshall Mark T | Medical electrical lead including an inductance augmenter |
US7729770B2 (en) | 2006-04-26 | 2010-06-01 | Medtronic, Inc. | Isolation circuitry and method for gradient field safety in an implantable medical device |
US7702387B2 (en) | 2006-06-08 | 2010-04-20 | Greatbatch Ltd. | Tank filters adaptable for placement with a guide wire, in series with the lead wires or circuits of active medical devices to enhance MRI compatibility |
US20070299490A1 (en) | 2006-06-23 | 2007-12-27 | Zhongping Yang | Radiofrequency (rf)-shunted sleeve head and use in electrical stimulation leads |
US7801623B2 (en) | 2006-06-29 | 2010-09-21 | Medtronic, Inc. | Implantable medical device having a conformal coating |
CN101100070A (en) * | 2006-07-04 | 2008-01-09 | 亿丰综合工业股份有限公司 | Honeycomb curtain cutting method and cutting machine |
US7731717B2 (en) | 2006-08-08 | 2010-06-08 | Covidien Ag | System and method for controlling RF output during tissue sealing |
US7610101B2 (en) | 2006-11-30 | 2009-10-27 | Cardiac Pacemakers, Inc. | RF rejecting lead |
US7747318B2 (en) | 2006-12-07 | 2010-06-29 | Neuropace, Inc. | Functional ferrule |
WO2008077037A2 (en) | 2006-12-18 | 2008-06-26 | Ergin Atalar | Mri compatible implantable devices |
US9044593B2 (en) | 2007-02-14 | 2015-06-02 | Medtronic, Inc. | Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding |
US10537730B2 (en) | 2007-02-14 | 2020-01-21 | Medtronic, Inc. | Continuous conductive materials for electromagnetic shielding |
US9345888B2 (en) | 2007-03-09 | 2016-05-24 | Cardiac Pacemakers, Inc. | MRI compatible implantable medical devices and methods |
EP2121125B1 (en) | 2007-03-09 | 2015-12-30 | Medtronic, Inc. | Medical device electrical lead design for preventing transmittance of unsafe currents to a patient |
JP5568315B2 (en) | 2007-03-19 | 2014-08-06 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | RF / MRI compatible lead wire |
EP2705874B1 (en) | 2007-03-19 | 2016-09-28 | Boston Scientific Neuromodulation Corporation | MRI and RF compatible leads |
US8187284B2 (en) | 2007-04-23 | 2012-05-29 | Boston Scientific Scimed, Inc. | Intraluminary stent relocating apparatus |
WO2009048652A1 (en) | 2007-10-11 | 2009-04-16 | Rentendo Corporation | Reduction of rf induced tissue heating using discrete winding patterns |
US20090099555A1 (en) | 2007-10-11 | 2009-04-16 | Ingmar Viohl | Reduction of rf induced tissue heating using conductive surface pattern |
US8483840B2 (en) | 2008-03-20 | 2013-07-09 | Greatbatch Ltd. | Dual function tuned L-C input trap passive EMI filter component network for an active implantable medical device |
US20090281592A1 (en) | 2008-05-08 | 2009-11-12 | Pacesetter, Inc. | Shaft-mounted rf filtering elements for implantable medical device lead to reduce lead heating during mri |
WO2010008833A1 (en) | 2008-06-23 | 2010-01-21 | Greatbatch Ltd. | Frequency selective passive component networks for implantable leads of active implantable medical devices utilizing an energy dissipating surface |
WO2010033911A2 (en) | 2008-09-22 | 2010-03-25 | Cardiac Pacemakers, Inc. | Styrene-isobutylene copolymers and medical devices containing the same |
US8301249B2 (en) | 2008-10-23 | 2012-10-30 | Pacesetter, Inc. | Systems and methods for exploiting the tip or ring conductor of an implantable medical device lead during an MRI to reduce lead heating and the risks of MRI-induced stimulation |
US8634931B2 (en) | 2008-10-30 | 2014-01-21 | Pacesetter, Inc. | MRI compatible implantable medical lead and method of making same |
US9399129B2 (en) | 2008-10-30 | 2016-07-26 | Pacesetter, Inc. | MRI compatible implantable medical lead and method of making same |
US20100138192A1 (en) | 2008-12-01 | 2010-06-03 | Pacesetter, Inc. | Systems and Methods for Selecting Components for Use in RF Filters Within Implantable Medical Device Leads Based on Inductance, Parasitic Capacitance and Parasitic Resistance |
EP2198917B1 (en) | 2008-12-19 | 2016-03-30 | Ela Medical | Generator for an implantable pacemaker, comprising means for commuting in safety mode during MRI tests |
WO2010078552A1 (en) | 2009-01-05 | 2010-07-08 | Kenergy, Inc. | Mri compatible electrical lead for an implantable electronic medical device |
-
2002
- 2002-04-15 WO PCT/US2002/011984 patent/WO2002083016A1/en not_active Application Discontinuation
- 2002-04-15 CA CA2482202A patent/CA2482202C/en not_active Expired - Lifetime
-
2009
- 2009-10-06 US US12/574,147 patent/US7689288B2/en not_active Expired - Lifetime
-
2013
- 2013-11-15 US US14/080,830 patent/US9248283B2/en not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9333038B2 (en) | 2000-06-15 | 2016-05-10 | Monteris Medical Corporation | Hyperthermia treatment and probe therefore |
US9387042B2 (en) | 2000-06-15 | 2016-07-12 | Monteris Medical Corporation | Hyperthermia treatment and probe therefor |
US10188462B2 (en) | 2009-08-13 | 2019-01-29 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9510909B2 (en) | 2009-08-13 | 2016-12-06 | Monteris Medical Corporation | Image-guide therapy of a tissue |
US9211157B2 (en) | 2009-08-13 | 2015-12-15 | Monteris Medical Corporation | Probe driver |
US10610317B2 (en) | 2009-08-13 | 2020-04-07 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9271794B2 (en) | 2009-08-13 | 2016-03-01 | Monteris Medical Corporation | Monitoring and noise masking of thermal therapy |
US8979871B2 (en) | 2009-08-13 | 2015-03-17 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US10548678B2 (en) | 2012-06-27 | 2020-02-04 | Monteris Medical Corporation | Method and device for effecting thermal therapy of a tissue |
US9492121B2 (en) | 2014-03-18 | 2016-11-15 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9700342B2 (en) | 2014-03-18 | 2017-07-11 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US10092367B2 (en) | 2014-03-18 | 2018-10-09 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9504484B2 (en) | 2014-03-18 | 2016-11-29 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US10342632B2 (en) | 2014-03-18 | 2019-07-09 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9486170B2 (en) | 2014-03-18 | 2016-11-08 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US9433383B2 (en) | 2014-03-18 | 2016-09-06 | Monteris Medical Corporation | Image-guided therapy of a tissue |
US10675113B2 (en) | 2014-03-18 | 2020-06-09 | Monteris Medical Corporation | Automated therapy of a three-dimensional tissue region |
US10327830B2 (en) | 2015-04-01 | 2019-06-25 | Monteris Medical Corporation | Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor |
US11672583B2 (en) | 2015-04-01 | 2023-06-13 | Monteris Medical Corporation | Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor |
Also Published As
Publication number | Publication date |
---|---|
US9248283B2 (en) | 2016-02-02 |
US7689288B2 (en) | 2010-03-30 |
CA2482202A1 (en) | 2002-10-24 |
WO2002083016A1 (en) | 2002-10-24 |
US20100016936A1 (en) | 2010-01-21 |
US20140074211A1 (en) | 2014-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2482202C (en) | Systems and methods for magnetic-resonance-guided interventional procedures | |
US9242090B2 (en) | MRI compatible medical leads | |
US7844319B2 (en) | Systems and methods for magnetic-resonance-guided interventional procedures | |
US7155271B2 (en) | System and method for magnetic-resonance-guided electrophysiologic and ablation procedures | |
Susil et al. | Multifunctional interventional devices for MRI: a combined electrophysiology/MRI catheter | |
JP5081244B2 (en) | Intervention device for RF ablation used in RF field | |
USRE44736E1 (en) | Magnetic resonance probes | |
US6393314B1 (en) | RF driven resistive ablation system for use in MRI guided therapy | |
AU2009251074B2 (en) | System and method for magnetic-resonance-guided electrophysiologic and ablation procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDC | Discontinued application reinstated | ||
MKEX | Expiry |
Effective date: 20220419 |